East Tennessee State University

Digital Commons @ East Tennessee
State University
Electronic Theses and Dissertations

Student Works

5-2019

Role of ATM in T Cell Dysfunction During Chronic Viral Infections
Juan Zhao
East Tennessee State University

Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Medical Microbiology Commons

Recommended Citation
Zhao, Juan, "Role of ATM in T Cell Dysfunction During Chronic Viral Infections" (2019). Electronic Theses
and Dissertations. Paper 3531. https://dc.etsu.edu/etd/3531

This Dissertation - unrestricted is brought to you for free and open access by the Student Works at Digital
Commons @ East Tennessee State University. It has been accepted for inclusion in Electronic Theses and
Dissertations by an authorized administrator of Digital Commons @ East Tennessee State University. For more
information, please contact digilib@etsu.edu.

Role of ATM in T Cell Dysfunction During Chronic Viral Infections

_____________________

A dissertation
presented to
the faculty of the Department of Internal Medicine, Surgery and Biomedical Science
East Tennessee State University
In partial fulfillment
of the requirements for the degree
Doctor of Philosophy in Biomedical Science
_____________________
by
Juan Zhao
May 2019
_____________________
Zhi Q. Yao, M.D., Ph.D., Chair
Alok Agrawal, Ph.D.
Chuanfu Li, M.D.
David L. Williams, Ph.D.
Jonathan P. Moorman, M.D., Ph.D.
Keywords: ATM, apoptosis, DNA damage repair, immune aging,
HCV, HIV, T cell homeostasis

ABSTRACT
Role of ATM in T Cell Dysfunction During Chronic Viral Infection
by
Juan Zhao
Hepatitis C virus (HCV) or human immunodeficiency virus (HIV) infection leads to a
phenomenon of inflammaging, in which chronic infection or inflammation induces an immune
aged phenotype with T cell dysfunction. Thus, HCV or HIV infection has been deemed as a
model to study the mechanisms of T cell infammaging and viral persistence in humans. In this
dissertation, T cell homeostasis, DNA damage and repair machineries were investigated in
patients with chronic HCV or HIV infection at risk for inflammaging. We found a significant
depletion in CD4 T cells, which was correlated with their apoptosis in chronically HCV/HIVinfected patients, compared to age-matched healthy subjects. In addition, virus-infected patients’
CD4 T cells were prone to DNA damage that extended to chromosome ends (telomeres), leading
to accelerated telomere erosion - a hallmark of senescence. Mechanistically, the DNA doublestrand break (DSB) sensor MRE11, RAD50, and NBS1 (MRN) remained intact, but the DNA
damage checkpoint kinase ataxia telangiectasia mutated (ATM) and its downstream checkpoint
kinase 2 (CHK2) were significantly suppressed in T cells from HCV/HIV-infected individuals.
Consistently, ATM/CHK2 activation, DNA repair, and cellular functions were also impaired in
primary CD4 T cells following ATM knockdown, or exposure to the ATM inhibitor (KU60019),
as well as in CD4 T cells co-cultured with HCV-infected hepatocytes, or a T cell line infected
with HIV-1 in the presence of raltegravir in vitro, which recapitulates the biological effects
observed in T cells in the setting of HCV/HIV infection in vivo. Importantly, ectopic expression
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of ATM was essential and sufficient to reduce the DNA damage, survival deficit, and cellular
dysfunction in T cells from both HCV and HIV-infected individuals. These results demonstrate
that failure of DSB repair due to ATM deficiency leads to unrepaired DNA damage and renders
virally infected patients’ T cells prone to senescence and apoptosis, thus contributing to CD4 T
cell loss or dysfunction during chronic HCV or HIV infection. This study reveals a novel
mechanism by which ATM deficiency promotes telomeric DNA damage and premature T cell
aging, and provides a new therapeutic target for inflammaging-induced immune dysfunction
during chronic viral infection.
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CHAPTER 1
INTRODUCTION
HCV Infection - An Excellent Model for Studying Viral Persistence in Humans
HCV is a parenterally-transmitted, hepatotropic virus that often causes inflammation of
liver (hepatitis). Currently, there is approximately 170-200 millions of people worldwide and 4
millions of United States (U.S.) citizens are infected by HCV. Upon exposure, 15-25% of HCVinfected subjects can spontaneously resolve the acute infection, and 75-85% of infected subjects
progress to chronic infection1,2. Chronic HCV infection is associated with an increased risk of
developing liver cirrhosis and hepatocellular carcinoma (HCC) (as showed in Fig.1.1), and is
now the leading infectious cause of liver transplantation in the US3. According to CDC
reporting4, the number of HCV-related deaths has reached an all-time high, surpassing 60 other
nationally reported infectious conditions combined. Thus, hepatitis C is the number one
infectious disease leading to death in the U.S. Over the past 7-8 years, the successful
development of highly effective direct-acting antiviral agents (DAAs) has led to a significant
paradigm change in the treatment of HCV infection. While DAA has significantly improved the
outcome of HCV treatment, these therapeutic cocktails are facing new issues such as viral
mutation, relapse, and reinfection following therapy5,6. Additionally, the lack of a vaccine for
this virus is a major hurdle to control this global infection.
Since HCV is highly efficient at establishing chronic infection via evasion of host
immunity, it has become an excellent model to study the mechanisms of viral persistence in
humans. Similar to the issues inherent to HCV infection, the failures to successfully manage
many chronic infectious diseases and to effectively respond to vaccines stem from an incomplete
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understanding of the host and pathogen interactions that may dampen the host immunity, thus
this research is significant in that the mechanisms we will study may ultimately be applicable to
multiple chronic infectious diseases.

Fig.1.1 Natural history of HCV infection. (Modified from Osna NA 2017)
Chronic hepatitis develops among 75%-85% of HCV-infected subjects. HCV can cause repeated
hepatocyte damage and result in cirrhosis with a rate of 15%-25% after 10-40 years. Among
patients with liver cirrhosis, there is 2-7% annual risk of hepatocellular carcinoma.
HIV Infection - An Excellent Model for Studying Inflammaging in Humans
HIV-1 was first discovered in 1983, and is the cause of the acquired immunodeficiency
syndrome (AIDS)7,8. There were approximately 36.9 million peoples worldwide living with
HIV/AIDS in 2017. More than 1.1 million peoples in the U.S. are living with HIV today. Since
1997, highly active combined Antiretroviral Therapy (ART) has been used to treat HIV
patients9,10. It is extremely effective at suppressing HIV replication, increasing CD4 T cell
counts, and decreasing the HIV/AIDS-related morbidity and mortality11-13. However, current
ART can only suppress, not eliminate, the HIV infection. Also, HIV patients on ART with
undetectable viremia and reasonable CD4 T cell counts still harbor impaired immune functions,
as evidenced by the shortened telomeres, low IL-2 production, poor cellular proliferative
capacity, and blunted vaccine responses14-24. Importantly, ART-controlled HIV patients often
13

exhibit a state of chronic, low grade inflammation that can activate the immune system, and
subsequently, drive T cell premature aging or senescence, a phenomenon called inflammaging2528

. Inflammaging is a major driver of increased susceptibility to infections, reduced responses to

vaccines, increased incidences of cancers, cardiovascular disease, and neurodegeneration, similar
to those often seen in the elderly29-31. The mechanisms regarding how inflammaging is developed
and persists in virus suppressed, latent HIV infection, however, remain poorly understood.
Multiple factors may be involved in the mechanisms underlying inflammaging in ARTcontrolled, latent HIV infection. Specifically, HIV latency in the era of ART is characterized by
the existence of viral reservoirs that prevent HIV-1 eradication and likely drive
inflammaging32,33. Thus, HIV-mediated inflammaging could result from a myriad of insults
(Fig.1.2) , including viral particles or viral proteins released from HIV-1 reservoirs, cell-secreted
pro-inflammatory cytokines/chemokines, HIV-enhanced gut permeability or altered gut
microbiota, frequent cytomegalovirus (CMV), Epstein–Barr virus (EBV), hepatitis B virus
(HBV), and HCV coinfections, ART regimens, and other closely associated comorbidities
including malignancies, or even social, personal stresses, and environmental factors34-37.
Additionally, cumulative evidence has indicated a tight link between oxidative stress and
inflammaging38. Oxidative stress refers to elevated intracellular levels of reactive oxygen species
(ROS) that cause damage to lipids, proteins and DNA, which may shape the homeostasis at
various disease conditions39-42. In the setting of latent HIV infection, ROS within the cellular
milieu during viral infection may also play an important role in driving inflammaging. The
inflammaging imposed by HIV exposes the immune system, particularly, HIV-infected and
bystander CD4 T cells, to unique challenges that lead to T cell exhaustion and senescence,
similar to that observed in the elderly. Therefore, the virus-suppressed, latent HIV infection
14

can be deemed as an excellent model to study inflammaging in humans.

Fig.1.2. Multiple factors involve in the mechanisms underlying HIV-mediated
inflammaging. (Modified from Hearps A 2016)
T Cell Aging or Senescence - A Phenomenon Often Seen in Chronic Viral Infection
Aging is associated with, and may be caused by, low-grade inflammation
(inflammaging), which is a common denominator in the majority of age-related diseases43-45.
Inflammaging is a major driver of increased susceptibility to infections, reduced responses to
vaccines, increased incidences of cancers, cardiovascular diseases, and neurodegeneration, all of
which contribute to comorbidity and mortality in the elderly29-31. The aged immune system,
typically hypo-responsive to specific infection and vaccination, can be hyper-responsive or
aberrant under non-specific inflammatory conditions. In human immune system, lymphocytes
including CD4 helper T cells are long-lived, and thus are exposed to extensive genomic insults
and replication pressure, making them vulnerable to aging-associated abnormalities. Recent
15

studies, including those reported by our lab, now link changes in immune aging directly to
chronic DNA damage responses (DDR), which can lead to remodeling of immune responses43-45.
In studying the role of CD4 T cell dysfunction in viral persistence, our lab, along with
others have found that chronic viral (HCV, HIV) infection can accelerate premature T cell aging,
as evidenced by overexpression of aging markers (such as KLRG1, CD57, p16ink4a, and βgalactosidase), differential regulation of age-associated microRNA-21/-181a, and, notably, an
accelerated loss of telomeres (Fig.1.3.), when compared to age-matched healthy subjects
(HS)17,46-58. Accelerated telomere loss is indicative of excessive cell proliferative turnover or
inadequate telomeric DNA maintenance. Telomeres are repeating hexameric sequences of DNA
(GGGATT) that are found at the ends of linear chromosomes in association with a complex of
proteins. Because of the enrichment of guanine (G) in telomeres, they are extremely sensitive to
DNA damage, especially to the oxidative ROS-induced DDR. Telomere integrity is a key feature
of the linear chromosomes that preserve genome stability and function; conversely, telomere
erosion is a hallmark of cell aging or senescence(a quiescent, non-replicative state) that drives
cell dysfunction or apoptosis59,60. While the telomere length is maintained in most cases by the
telomerase that prolongs telomeric sequence61-64, a telomere-bound protein complex (Shelterin)
is required to protect telomeres from unwanted DDR65-69. Notably, several DNA repair
pathways, including ATM (ataxia telangiectasia-mutated protein), ATR (ataxia telangiectasia
and Rad3-related protein), and DNA-PKCs (DNA-dependent protein kinase catalytic subunit)
are involved in the DDR43,70-73; however, how the telomeric DNA damage and repair signaling
pathways are dysregulated in the context of viral infection remain largely unknown. It is thus
important to elucidate the mechanisms underlying T cell senescence and inflammaging that is
characterized by telomere erosion in individuals with chronic viral infection.
16

Fig.1.3. Relationship between cell division and changes in telomere length. (Modified
from Richard J. Hodesa 1999)
The rate of telomere loss has been measured as 50–100 bp per cell division from in vitro
analysis of cultured human lymphocytes. Under chronic HCV/HIV infection, the telomere
loss can be as high as 250 bp per cell division and lead to T cell premature aging.

ATM - A Kinase Involves in Regulating DDR and Multiple Cellular Functions
Because DNA damage can cause telomere erosion, leading to premature cell senescence
and/or apoptosis59,74, we hypothesized that progressive CD4 T cell loss and failure of immune
recovery during chronic viral infection could be, at least in part, due to a deficiency in the DNA
repair that alters telomere integrity. Human CD4 T cells have a relatively long life span (150-160
days) and thus are exposed to a multitude of genotoxic stresses, leading to ~1% out of a pool of
300 billion T cells to be replaced daily75. To maintain genomic stability and cell survival, cells
continuously recognize and respond to DNA damage by either activation of DNA damage
checkpoints to arrest cell cycle progression and allow for repair, or, if the damaged DNA is
beyond repair, to undergo apoptosis76. Notably, a major sensor of DSB is the MRN complex,
17

which subsequently recruits the protein kinase ATM, an enzyme critically involves in repairing
DNA damage for cell survival (Fig.1.4)77,78.

Fig.1.4. ATM protein kinase response to double stranded breaks. (Modified from Van Gent,
D. C. 2001)
A major sensor of DSB is the MRN complex, which subsequently recruits the ATM protein
kinase. Downstream targets of ATM phosphorylation include CHK2 and p53. By this process,
ATM can influence DSB repair and cell-cycle progression, in addition to cell death through
apoptosis. Because the ATM protein is one of most widely studied components in the cellular
response to DNA damage, it has been placed in the center of this figure. However, numerous
other factors, including ATR and DNA-PKc protein kinases, are essential for cell-cycle
modulation after the presence of DNA damage, and some of its functions might be redundant
with ATM. (The red bars indicate the three main cell-cycle checkpoints and dashed lines show
that the effect is not a principal pathway).
ATM was originally identified in individuals with ataxia telangiectasis (AT), an
autosomal recessive disorder that manifests with progressive ataxia, telangiectasia,
immunodeficiency, genomic instability, and cancer predisposition79. It is a key kinase within the
18

DDR signaling cascade80,81, and plays a unique role in lymphocyte biology, as programmed
DDR participates in the gene remodeling process necessary for formation of a highly diverse
TCR repertoire. ATM requires a signal for activation (usually a DNA damage signal), which
promotes intermolecular auto-phosphorylation of ATM via the serine residue at position 1981,
resulting in its inactive dimer to dissociate into active monomers82. Accumulation of damaged
DNA activates the ATM cascades, along with ATR and DNA-PKc, all of which belong to the
PI3K-related kinase (PIKK) family and are important for DNA reprogramming and T cell
rearrangement 79-82. However, how ATM is dysregulated in CD4 T cells in the setting of chronic
viral infection remains unknown.

Specific Aims
The overall goal of this study is to elucidate the mechanisms by which chronic viral
infection mediates DNA damage and telomere erosion that may lead to T cell dysfunction. To
this end, we will employ a large cohort of individuals with chronic HCV or HIV infection
because they have been deemed as great models to study inflammaging and T cell dysregulation
in humans.
To explore the mechanisms of T cell dysfunction in virally infected individuals, we have
recently focused on identifying biomarkers for T cell aging in HCV- or HIV-infected subjects.
We found that HCV- or HIV-infected individuals exhibit a profound impairment in CD4 T cell
responses, concomitant with overexpression of exhaustion and aging markers, such as
programmed death 1 (PD-1), T cell immunoglobulin domain 3 (Tim-3), killer cell lectin-like
receptor subfamily G 1 (KLRG-1), and dual specific phosphatase 6 (DUSP-6) in CD4 T cells
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when compared to age-matched HS. These findings suggest that T cell dysfunction during
HCV/HIV infection may be a result of profound, virus-mediated, premature T cell aging.
Notably, this aging process, as in the elderly, not only involves antigen-specific effector and
memory T cells, but also extends to naïve T cells that are the primary subsets responding to neoantigens (vaccines). Importantly, these dysfunctional T cells also suffer telomere erosion - a
hallmark of cell aging - indicating excessive proliferative pressure or telomeric DNA damage in
chronic viral infection.

Telomere integrity is a key feature of linear chromosomes that preserves genome stability
and function; whereas telomere erosion is a hallmark of cell aging or senescence that leads to cell
dysfunction or apoptosis; thus telomeric DNA repair is essential to cell survial. While the
telomere length is maintained in most cases by a telomerase that prolongs telomeric DNA, we
found that telomerase activity is intact, whereas ATM, a DNA repair enzyme, is inhibited in CD4
T cells during HCV and HIV infection. How DNA damage repair signaling pathways are
dysregulated in T lymphocytes in the context of HCV/HIV infection, and their roles in T cell
aging and dysfunction, remain largely unknown.

In this study, we hypothesize that i) DNA damage and telomere loss play a pivotal role in
T cell aging and dysfunction in HCV/HIV-infected subjects; and ii) lack of ATM-dependent
DNA damage repair accelerates T cell aging and dysfunction in HCV/HIV infection, and as
such, restoring this DNA repair machinery may open new avenues to protecting T cells from
aging and maintaining immune competence. To test this hypothesis, we propose the following
two independent but interrelated aims:
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Aim 1. Determine the role of ATM in DNA damage and T cell dysfunction in
chronic HCV infection.

A) Compare T cell homeostasis, apoptosis, and DNA damage in HS and HCV
chronically-infected individuals.

B) Evaluate the role of ATM in regulating DNA damage repair and maintaining T cell
functions during HCV chronic infection.

The objectives of these studies are to determine the relationship of DDR with T cell
apoptotic death and the role of ATM in preserving DNA integrity and T cell function during
HCV infection.

Aim 2. Investigate the role of ATM in telomeric DNA damage and T cell dysfunction
during latent HIV infection.

A) Characterize T cell homeostasis, apoptosis and their relationships with telomeric DNA
damage in HIV+/- subjects.

B) Explore the role of ATM in repairing telomeric DNA damage and maintaining T cell
functions in HIV+/- subjects.

The objectives of these studies are to evaluate the role of ATM in regulating telomeric
DNA damage repair and T cell function during latent HIV infection.
These translational studies are significant and timely in that they will provide a working
model to explore mechanisms that may be fundamental to diminishing immune responses that
21

are observed in multiple chronic infectious diseases, including but not limited to HCV and HIV
infection. Understanding such mechanisms is critical for developing approaches to improve
immune responses in the setting of immunocompromised conditions.
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Abstract
T cells have a crucial role in viral clearance and vaccine response; however, the
mechanisms regulating their responses to viral infections or vaccinations remain elusive. In this
study, we investigated T-cell homeostasis, apoptosis, DNA damage, and repair machineries in a
large cohort of subjects with hepatitis C virus (HCV) infection. We found that naive CD4 T cells
in chronically HCV-infected individuals (HCV T cells) were significantly reduced compared
with age-matched healthy subjects. In addition, HCV T cells were prone to apoptosis and DNA
damage, as evidenced by increased 8-oxoguanine expression and γH2AX/53BP1-formed DNA
damage foci - hallmarks of DNA damage responses. Mechanistically, the activation of DNA
repair enzyme ataxia telangiectasia mutated (ATM) was dampened in HCV T cells. ATM
activation was also diminished in healthy T cells exposed to ATM inhibitor or to HCV (core
protein) that inhibits the phosphoinositide 3 kinase pathway, mimicking the biological effects in
HCV T cells. Importantly, ectopic expression of ATM was sufficient to repair the DNA damage,
survival deficit, and cell dysfunctions in HCV T cells. Our results demonstrate that insufficient
DNA repair enzyme ATM leads to increased DNA damage and renders HCV T cells prone to
apoptotic death, which contribute to the loss of naive T cells in HCV infection. Our study reveals
a novel mechanism for T-cell dysregulation and viral persistence, providing a new strategy to
improve immunotherapy and vaccine responses against human viral diseases.

Introduction
Hepatitis C virus (HCV) is a blood-born pathogen characterized by a high rate (> 80%) of
chronic infection, which can progress to liver cirrhosis and hepatocellular carcinoma - a leading
cause for liver transplantation 1. Notably, HCV has evolved numerous strategies to evade host
24

immunity and harness virus persistence 1, providing an excellent model to study the mechanisms
of virus-mediated host immune dysfunction in humans.We and others have previously reported
that patients with chronic HCV infection, exhibit premature T cell aging, as demonstrated by
overexpression of aging markers and telomere attrition- indicating excessive proliferative
turnover or inadequate telomeric maintenance 2-6. However, the molecular mechanisms that
control T cell homeostasis and virus persistence in humans remain unclear.
T-cell homeostasis is tightly controlled, requiring a ﬁne balance between inﬂux of newly
generated T cells from thethymus and efﬂux by consumption via T-cell apoptosis, and selfreplication within the existing pools of T lymphocytes 7, 8. With de ﬁcient thymic inﬂux in aging
adults, the immune system responds to in vivo and in vitro challenges by expanding existing T
cells, leading to increased proliferative turnover, telomere attrition, and cell apoptosis 7, 8. We
hypothesize that premature T cell aging not only involves virus-specific effector and memory T
cells engaging in chronic viral infection, but may also extend to the compartment of naïve T cells
that are unprimed by antigens. In support of this notion, broad regulatory anomalies, including
the markers for T cell exhaustion and senescence, are found not only expressed on virus-specific
T cells, but also on unprimed naïve T cells that have not yet engaged in immune responses2-6, 9-14.
This notion is also supported by the observations that individuals with chronic viral (HCV or
HIV) infection often have blunted vaccine responses, suggesting a broad and shared mechanism
of immune dysregulation, particularly naïve CD4 T cell dysfunction, and vaccine nonresponsiveness in virally infected individuals 2, 3, 15-19.
Human naïve T cells have a relatively long life span (150~160 days) and thus are
exposed to a multitude of genotoxic stressors, leading to 1% of a pool of 300 billion T cells to be
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replaced daily 7, 8. Notably, naïve T cells are typically resistant to death receptor/ligand (Fas/FasL)-mediated apoptosis, pointing toward cell-internal signals as apoptosis initiators 20. One of the
internal stressors linked to apoptosis is damaged DNA, which is particularly important in
senescent cells that have been chronically exposed to the endogenously generated reactive
oxygen species (ROS) 21. To maintain genomic stability and cell survival, cells continuously
recognize and respond to this DNA damage which will either activate DNA damage checkpoints
to arrest cell cycle progression and allow for repair, or, if the damaged DNA is beyond repair,
undergo apoptosis 22.
A major sensor of DNA breaks is the MRN complex (MRE11, RAD50, and NBS1),
which subsequently recruits the protein kinase ataxia telangiectasia mutated (ATM), an enzyme
critically involved in repairing DNA double strand breaks (DSBs) for cell survival 23, 24. ATM
was originally identified in individuals with ataxia telangiectasis, an autosomal recessive
disorder exhibiting progressive ataxia, telangiectasia, immunodeficiency, genome instability, and
cancer predisposition 25. ATM, accompanied by ataxia telangiectasia Rad3-related (ATR) and
DNA-dependent protein kinase catalytic subunit c (DNA-PKc), is the pinnacle kinase of the
DNA repair signaling cascade, and belongs to the phosphoinositide 3 kinase (PI3K)-related
kinase family 26. Accumulation of DNA DSBs activates ATM cascades, along with other DNA
damage repair machineries, which are important for DNA reprogramming and cell remodeling.
To identify factors that perturb T cell homeostasis during HCV infection, we investigated
the mechanism that controls T cell survival and DNA damage repair capabilities in primary CD4
T cells. We demonstrate that insufficiency of ATM leads to accumulation of DNA damage,
rendering naive CD4 T cells sensitive to apoptosis and T cell loss, contributing to viral
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persistence and vaccine non-responsiveness in chronic HCV infection.

Materials and Methods
Subjects
The study protocol was approved by the institutional review board (IRB) of East
Tennessee State University and James H. Quillen VA Medical Center (ETSU/VA IRB, Johnson
City, TN, USA). The study subjects were composed of two populations: 148 chronically HCVinfected individuals and 72 age-matched HS. Written informed consent was obtained from all
participants. HCV patients were virologically positive for HCV RNA, prior to the antiviral
treatment. Healthy subjects, derived from Physicians Plasma Alliance, Gray, TN, USA were
negative for HBV, HCV, and HIV infection.

Cell Isolation and Culture
PBMCs were isolated from whole blood by Ficoll (GE Heathcare, Piscataway, NJ, USA)
density centrifugation. Naïve and memory CD4+ T cells were isolated from PBMCs using the
Naïve or Memory CD4+ T Cell Isolation Kit and a MidiMACS™ Separator (Miltenyi Biotec
Inc., Auburn, CA). The isolated T cells were cultured in RPMI 1640 medium containing 10%
FBS (Atlanta Biologicals, Flowery Branch, GA, USA), 100 IU/ml penicillin and 2 mM Lglutamine (Thermo Scientific, Logan, UT, USA) without mitogenic stimulation for 4 days at
37°C and 5% CO2 atmosphere. Cells were collected at day 0, day 2, or day 4 for detection of cell
apoptosis and DNA damage. To test the role of pATM in repairing DNA damage and apoptosis,
10μM pATM inhibitor (KU60019, Abcam, Cambridge, MA) or dimethyl sulphoxide were added
to the cultures for 48 h, followed by apoptosis and DNA damage analysis. To consolidate the
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role of HCV in inhibiting ATM activation, purified naïve CD4 T cells were co-cultured with
Huh7.5 cells with or without HCV infection, or 1μg/ml recombinant HCV core protein (Virogen,
watertown, MA, USA) or control protein β-galactosidase (Virogen), in the presence or absence
of 20 μM PI3K inhibitor (LY294002, Sigma) for 4 days, followed by flow cytometry or Western
blot analysis for ATM/pATM expression, DNA damage, and cell apoptosis.

Flow Cytometry
For phenotypic analysis of naïve CD4 T cells, PBMCs were stained with CD4-APC,
CD45RA-FITC (BioLegend, San Diego, CA, USA) antibodies or isotype controls. To quantify
cell apoptosis, naïve or memory cells were purified, cultured, and collected at indicated days and
stained with Av and 7-AAD using BD Pharmingen™ PE Av Apoptosis Detection Kit I (BD
Biosciences, San Jose, CA, USA). For intracellular staining, the cells were fixed and
permeabilized with Foxp3 Transcription Factor Staining Buffer Set (eBioscience, San Diego,
CA, USA), and stained with pATM (Ser1981)-PE antibody(BioLegend), ATM antibody
(Abcam) and anti-Rabbit-IgG-Alexa Fluor 488 (Santa Cruz Biotechnology, Dallas, TX, USA),
pCHK2 (Thr68)-PE antibody (eBioscience), 8-oxoguaine-FITC probe (OxyDNA Assay Kit,
EMD Millipore, Billerica, MA).The stained cells were analyzed on AccuriTM C6 flow
cytometer (BD, Franklin Lakes, NJ), and data were analyzed by FlowJo software (Tree Star, Inc.,
Ashland, OR). Isotype control antibodies (eBioscience) and fluorescence minus one controls
were used to determine the background levels of staining and adjust multicolor compensation as
gating strategy.
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RNA Isolation and Real-time RT-PCR
Total RNA was extracted from 1.0 × 106 cells with PureLink RNA Mini Kit (Invitrogen,
Carlsbad, CA), and cDNA was synthesized by using High Capacity cDNA Reverse Transcription
Kit (Applied Bio systems, Foster city, CA) per manufacturer’s instruction. Quantitative PCR
were completed in triplicates following the conditions 95 °C, 10min and then 95°C, 15s; 60°C,
60s with 40 cycles. Gene expression was normalized to 18S ribosomal RNA and expressed as
fold changes using the 2-ΔΔct method. Primer sequences were shown in Table2.1.

Western Blotting
Naïve CD4 T cells purified from HCV-infected individuals and HS were lysed on ice
in RIPA lysis buffer (Boston BioProducts Inc, Ashland, MA) in the presence of protease
inhibitors (Thermo Scientific, Rockford, IL). The protein concentrations were measured by
Pierce BCA protein assay kit (Thermo Scientific). Proteins were separated by SDS-PAGE,
transferred to polyvinylidene difluoride membranes, which were blocked with 5% nonfat
milk, 0.5% Tween-20 in Tris buffered saline, and incubated with the pATM (Ser1981)
(D6H9), pBRCA1, pCHK1, and pCHK2 (Thr68) (C13C1) antibodies and βActin (8H10D10)
antibodies (Cell Signaling, Danvers, MA). Appropriate horseradish peroxide-conjugated
secondary antibodies (Cell Signaling) was then used and proteins were detected using
Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare BioSciences,
Pittsburgh, PA). Membranes were stripped and re-probed with MRE11, RAD50, NBS1,
BRCA1, ATM (D2E2), γH2AX, PARP, CHK1, and CHK2 (D9C6) antibodies (Cell
Signaling). Protein bands were captured and quantitatively analyzed by Chemi DocTM MP
Imaging System (Bio-Rad System).
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Table 2.1 Primer sequences to be used in the chapter 2
Name of the amplified genes

Primer sequences

ATM

F: 5'-TGGATCCAGCTATTTGGTTTGA-3'
R: 5'-CCAAGTATGTAACCAACAATAGAAGAAGTAG-3'

p53

F: 5'-TCAACAAGATGTTTTGCCAACTG-3'
R: 5'-ATGTGCTGTGACTGCTTGTAGATG-3'

MRE11

F: 5'-CTTGTACGACTGCGAGTGGA-3'
R: 5'-TTCAC CCATCCCTCTTTCTG-3'

NBS1

F: 5'-TTGGTTGCATGCTCTTCTTG-3'
R: 5'-GGCTGCTTCTTGGACTCAAC-3'

RAD50

F: 5'-CTTGGATATGCGAGGACGAT-3'
R: 5'-CCAGAAGCTGGAAGTTACGC-3'

BRCA1

F: 5'-GGCTATCCTCTCAGAGTGACA-3'
R: 5'-CTGATGTGCTTTGTTCTGGA-3'

CHEK1

F: 5'-GGTGAATATAGTGCTGCTATGTTGACA-3'
R: 5'-TTGGATAAACAGGGAAGTGAACAC-3'

CHEK2

F: 5'-CCCAAGGCTCCTCCTCACA-3'
R: 5'-AGTGAGAGGACTGGCTGGAGTT-3'

18S ribosomal RNA

F: 5'-CCTGGATACCGCAGCTAGGA-3'
R: 5'- GCGGCGCAATACGAATGCCCC-3'
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Confocal Microscopy
Naïve CD4+ T cells were isolated and cultured as described above. Immunofluorescence
staining was performed according to the reported method 39. In brief, the cells were fixed in 2%
paraformaldehyde for 20 min, permeabilized with 0.3% Triton X-100 in PBS for 10 min,
blocked with 5% BSA in PBS for 1 h, and then incubated with rabbit anti-53BP1 antibody (Cell
Signaling) and mouse anti-γ-H2AX (Ser139) antibody (Biolegend) at 4 °C overnight. The cells
were washed with PBS with 0.1% Tween-20 for three times, and then stained with anti-rabbit
IgG-Alexa Fluor 488 and anti-mouse IgG- Alexa Fluor 555 (Invitrogen) at room temperature for
1 h, washed and mounted with DAPI Fluoromount-G (SouthernBiotech, Birmingham, AL).
Images were acquired with a confocal laser-scanning inverted microscope (Leica Confocal,
Model TCS sp8, Germany).

ATM Transfection
Purified naïve CD4+ T cells from HCV patients were transfected with 2.5 µg pcDNA3.1
(a gift from Adam Antebi 48, Addgene plasmid # 52534), or pcDNA3.1(+)Flag-His-ATM wt (a
gift from Michael Kastan 49, Addgene plasmid # 31985), or hATMS1981A mutant (a gift from
Michael Kastan 31, Addgene plasmid # 32300), using the Human T Nucelofector Kit and
Nucleofector I Device (Lonza, Allendale, NJ). 24 h post transfection, GFP fluorescence was
observed under microscope and the GFP expression level was measured by Flow Cytometry. 48
h post transfection, transfection efficiencies were monitored by flow cytometry measuring the
frequency of His+ cells. Ectopic ATM expression was detected by western blot. Active caspase3, γH2AX, and IL-2 expressions were assessed in the His-positive cells by Flow Cytometry.
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Statistical Analysis
The data were summarized as mean ± SEM or median with interquartile range and
analyzed using Prism 7 software. Comparisons between two groups were made using
independent Student's t test or Mann Whitney test, paired T test or Wilcoxon matched-pairs
signed rank test. Multiple groups were analyzed by one-way ANOVA test. P-values <0.05,
<0.01, or <0.001 were considered statistically significant or very significant, respectively.

Results
Naïve CD4 T Cell Apoptosis and Loss in HCV-Infected Patients
As an initial approach to identify factors that perturb T cell homeostasis in HCV
infection, we characterized the frequencies of primary T cells and their survival rate or
susceptibility to apoptosis in individuals with chronic HCV infection (n=68) versus age-matched
healthy subjects (HS) (n=38). We first analyzed total CD4+, CD45RA+CD4+ (naïve), and
CD45RA-CD4+ (memory) T cell frequencies in the peripheral blood mononuclear cells (PBMCs)
using flow cytometry. As shown in Fig.2.1A (representative dot plots and summary data), while
the total CD4 T cell numbers in PBMCs were slightly lower in HCV patients, the compartment
of naïve CD4 T cells was significantly reduced (P<0.0001), whereas memory CD4 T cells were
expanded in chronically HCV-infected subjects compared to HS. To exclude the possibility that
the gated PBMCs may include some CD4-expresing monocytes, we further gated on CD3+ T
cells, followed by analyzing CD45RA+CD3+CD4+ (naïve) and CD45RA-CD3+CD4+ (memory) T
cell populations, which produced similar results; i.e., chronic HCV subjects exhibited a
significant contraction of naïve T cell pools and expansion of memory T cells in their peripheral
blood (data not shown). Notably, the loss of naïve CD4 T cells from chronically HCV-infected
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subjects did not correlate with HCV genotype, viral load, or hepatic transaminase levels (data not
shown). This observation is in line with the previous reports showing a reduced naïve CD4 T cell
number - reflecting a state of immune activation and exhaustion in patients with chronic HCV
infection9, 10.
Apoptosis represents a major mechanism for controlling T cell homeostasis in adults 7.
The vast majority of CD4 T cells in vivo are in a resting state and, accordingly, do not undergo
apoptosis. When removed from their natural resources and kept ex vivo, human T cells
spontaneously and progressively go through the programmed cell death (spontaneous apoptosis).
To explore whether apoptosis contributes to the naïve T cell loss in HCV-infected individuals,
we purified CD4+CD45RO- naïve and CD4+CD45RA- memory T cells from HCV+/- subjects and
cultured the cells without stimulation for 0, 2, 4 days, followed by measuring the Annexin V
(Av) / 7-Aminoactinomycin D (7AAD) expressions. As shown in Fig.2.1B and C, although
healthy T cells showed signs of apoptosis/death accrual, an increased T cell apoptosis and
decreased cell survival rate were observed in HCV-infected patients, especially in the naïve CD4
T cell pools. By day 4 in culture without stimulation, 90% of healthy naïve T cells were alive,
whereas only 75% of the HCV naïve T cells still remained survival. Notably, increased apoptotic
propensity (Av expression) was inversely associated with cell survival rate, with HCV naïve T
cells more prone to spontaneous apoptosis compared to the HS. By day 4 in culture without
stimulation, HCV naïve T cells exhibited significant apoptosis compared with HS (~40% vs.
~20%, P<0.05), which negatively correlated with the cell numbers present in the peripheral
blood from the same individuals (data not shown). These results suggest that apoptotic
susceptibility of T cells from HCV-infected subjects may be one mechanism contributing to the
disproportionate T cell loss, , whereas lack of thymic inﬂux in aging adults and increase of naïve
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T cell differentiation into antigen speciﬁc effector and memory T cells during persistent viral
infection may be other mechanisms for the different outcomes of the two T-cell subsets.

Fig.2.1. T cell homeostasis and apoptosis in HCV-infected patients versus age-matched HS.
A) Naive CD4 T-cell loss in HCV patients vs. agematched HS. PBMCs isolated from HCVinfected patients and HS were analyzed using flow cytometry for T cell homeostasis.
Representative dot-plots and summary data of the flow cytometry for the percentages of total
CD4+, CD45RA+CD4+ (naïve), and CD45RA-CD4+ (memory) T cell frequencies are shown.
Each symbol represents one particular subject; the mean ± SE and p value of the statistical
analysis are shown, NS = no significance. (continued on the next page). B) & C)
Susceptibility of T cells to spontaneous apoptosis and death in HCV patients vs. HS. Naïve and
memory CD4 T cells were purified from PBMCs of the subjects, cultured in vitro without
stimulation for 0, 2, and 4 days, followed by flow cytometric analysis of Annexin V and 7AAD
expression. Representative dot plots for the cell purity, gating strategy, and summary data for the
percentages of survival cells as well as apoptotic cells are shown. n = the number of subjects
studied in each group. NS = no significance. P value with significant changes are shown.
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Fig.2.1 (continued)
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DNA Damage in Naïve CD4 T Cells from HCV-Infected Patients
Why naïve CD4 T cells are susceptible to apoptosis and loss in virally-infected individuals
is unclear. Unlike activated or memory T cells, resting naïve T cells typically do not express Fas
surface receptor(Fig.2.1SA). In addition, blocking the extrinsic death pathways by disrupting
Fas-Fas ligand, TNFα-TNF receptor, and TRAL-TRAIL receptor interactions in CD4 T cells did
not affect cell apoptosis or death rates (data not shown), indicating they are resistant to the
exogenous apoptotic pathway-mediated cell death, but sensitive to endogenous oxidative stress
(particularly ROS-mediated genotoxicity) 20. To assess endogenous DNA damage as a possible
cause of impaired T cell survival, CD4+CD45RO- naïve and CD4+CD45RA- memory T cells
were isolated from HCV-infected patients and age-matched HS, cultured in vitro without
stimulation for 0-4 days, followed by DNA integrity anaysis by measuring the expression of 8oxogunine (8-oxoG), a marker for DNA DSBs that are caused by excessive oxidative stress 21.
As shown in Fig.2.2A and B (representative overlaid histogram and summary data of flow
cytometry), resting naive CD4 T cells derived from HCV-infected patients had significantly
higher expression of 8-oxoG DNA bases compared to HS, indicating an accumulation of DNA
lesions during chronic viral infection. After culturing cells without mitogenic or antigenic
stimulation, both HCV and HS T cells showed increases in the expression of 8-oxoG. However,
the extent of this increase in HCV naïve T cells was less than that in HS. This could be
attributed to (i) the relatively high baseline 8-oxoG level in HCV naïve T cells at day 0, and (ii)
the test saturation of 8-oxoG load in T cells under these culture conditions with oxidative DNA
stress which could limit the 8-oxyG differences between HCV and HS T cells at day 4 in culture.
In contrast, memory T cells from HCV and HS exhibited an overload of 8-oxoG at baseline.
After culturing cells without stimulation, 8-oxoG levels only slightly increased, although HCV
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memory T cells exhibited marginally higher DNA lesions than HS at baseline (day 0) and 4 days
in culture. These data indicate that naïve T cells from HCV patients exhibit oxidative DNA
DSBs that remains unrepaired during viral infection.
Following genotoxic insult, histone variant H2AX is recruited to the site of DNA-DSB and
becomes phosphorylated at its C-terminal Ser-139 residue to form the γH2AX complex, which
subsequently acts as a docking site for other mediators or adaptor proteins, such as 53BP1, to
form microscopically visible nuclear focus (DNA damage foci) - a hallmark of DNA damage
response (DDR) 27, 28. To confirm that DNA damage occurs in T cells during HCV infection, we
purified naïve and memory CD4 T cells from HCV+/- subjects, and compared DNA damage foci
by examining the colocalization of γH2AX/53BP1 per nuclei using confocal microscopy. As
shown in Fig.2.2C (representative imaging and summary data of confocal microscopy), the
number of DNA damage foci was significantly higher in the naïve CD4 T cells freshly isolated
from HCV patients compared with the HS. We also observed an increase in DNA damage foci in
memory CD4 T cells derived from HCV patients versus HS (Supplementary Fig 2S1B). When
the cells were cultured without stimulation for 4 days, the DNA damage foci increased, and were
significantly higher in the naïve CD4 T cells from HCV patients compared with the HS. These
results, in conjunction with the changes in T cell frequency and apoptotic death, suggest that
unrepaired DNA damage is associated with T cell apoptosis and loss in individuals with chronic
HCV infection, emphasizing the role of DNA damage repair to secure T cell survival.
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Fig.2.2 DNA damage in CD4 T cells from HCV-infected patients versus age-matched HS.
A) & B) 8-oxyguanine expression in CD4 T cells. Naïve and memory CD4 T cells were purified
from PBMCs of HCV-infected patients and HS, followed by flow cytometric analysis of 8oxyguanine expression. Representative overlaid histogram and summary data for mean
florescence intensity (MFI) of 8-oxyguanine expression are shown. (continued on the next
page). C) Co-localization of 53BP1 and γH2AX in CD4 T cells. Naïve CD4 T cells were isolated
from PBMCs of HCV patients and HS, cultured in vitro without stimulation for 0-4 days,
followed by confocal microscopic analysis of 53BP1 and γH2AX co-localization in the nuclei.
100 cells were counted per subjects. N=number of subjects studied. P values of the DNA damage
foci per nuclei in the two groups are shown in the summary data.
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Fig.2.2 (continued)

DNA Damage Sensing and Repairing Machineries in Naïve CD4 T Cells from HCVInfected Individuals
Accumulation of DNA-DSBs in CD4 T cells from HCV patients indicates that the DNA
damage sensing and repairing machinery is disrupted. Essential components of this machinery
include DNA damage sensors, such as MRN complexes (MRE11, RAD50, and NBS1), which
recruit and mediate the DNA repair kinase ATM that can phosphorylate several downstream
checkpoint proteins (such as p53, BRCA1, CHK1 and CHK2) 22-24. To investigate the cellular
machineries that contribute to the DNA damage repair, we examined mRNA transcripts and
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protein expressions of these DDR molecules in CD4 T cells from HCV-infected patients and HS
using realtime RT-PCR and western blotting or flow cytometry. As shown in Fig.2.3A, the
mRNA levels of MRN complexes showed no difference or higher levels of MRE11, RAD50, and
NBS1. In parallel, the protein levels of these DNA damage sensors in naïve CD4 T cells were
also unchanged or slightly higher in HCV compared with HS (Fig.2.3B). Intriguingly, altrough
the mRNA level of ATM was higher (Fig.2.3C), its protein level was lower; particularly, ATM
phosphorylation (pATM) was significantly lower in HCV naïve CD4 T cells in the 4-day culture
compared to the HS, as measured by flow cytometry (Fig.2.3D) and western blot (Fig.2.3E).
Similarly, the mRNA expressions of ATM signaling molecules, P53, 53BP1, BRCA1, CHK1,
and CHK2 remained unchanged or even higher in naïve CD4 T cells from HCV patients when
compared to the HS (Fig.2.3F). However, pp53 protein was undetectable in resting naïve CD4 T
cells without stimulation, whereas BRCA1 and CHK1 total and phosphorylated proteins
remained unchanged (Fig.2.3G); CHK2 protein, especially pCHK2, was significantly suppressed
in HCV T cells compared to HS as demonstrated by western blot and flow cytometry (Fig.2.3H).
These results suggest that the DNA damage sensing machinery is intact, but the DNA repair
(ATM/CHK2) pathway is inhibited, at the post-transcriptional levels, especially the
phosphorylation process essential for its activation and function.
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Fig.2.3. DNA damage repair ATM signaling pathway in T cells of HCV-infected patients vs
age-matched HS.
A) DNA damage sensor MRN complex expressions in CD4 T cells. Naïve CD4 T cells were
isolated from 6 HCV-infected patients and 6 age-matched HS, cultured in vitro without
stimulation for 4 days, followed by real-time RT-PCR assay for MRE11, RAD50, and NBS1
mRNA expression. B) MRN protein expression detected by Western blot in naïve CD4 T cells
derived from HCV patients vs. HS. Representative imaging and summary data from multiple
subjects are shown. C) ATM mRNA expressions in CD4 T cells. Naïve CD4 T cells were
isolated from the study subjects as indicated, cultured in vitro without stimulation for 4 days,
followed by RT-PCR analysis for ATM mRNA level. D&E) Flow cytometry and western blot
analysis for ATM total and phosphorylated protein expression in naïve CD4 T cells from HCV
patients vs HS. (continued on the next page). F-H) ATM signaling molecule mRNA and
protein expressions in CD4 T cells. Naïve CD4 T cells were isolated from the study subjects,
cultured in vitro without stimulation for 4 days, followed by RT-PCR analysis for P53, BRCA1,
CHK1 and CHK2 mRNA level, western blot assay for their total and/or phosphorylated protein
levels. pCHK2 expression was confirmed by flow cytometry analysis.
41

Fig.2.3. (continued)
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Role of HCV in Dampening ATM Activation and Its Effects on DNA Damage and Cell
Apoptosis
As chronically HCV-infected patients often have other co-morbidities that may cause
immune dysregulation, we examined the specific role of HCV in triggering DDR and promoting
cellular senescence or apoptosis. We incubated naïve CD4 T cells with Huh7.5 cells with or
without HCV infection, followed by measuring ATM activation. As shown in Fig.2.4A
(immunofluorescence staining of Huh7.5 cells with or without infection by HCV JFH-1 strain),
hepatocytes transfected with HCV RNA at 48 h showed positive expression of HCV core
protein, whereas cells with mock transfection exhibited negative staining. Moreover, we detected
HCV RNA in the supernatant of HCV-transfected cells (at 24 h as well as 48 h) but not mocktransfected cells (data not shown). Importantly, similar to the observations in HCV patients
(Fig.2.3B), wherase the total ATM protein expression was not significantly decreased, the
phosphorylation of ATM was markedly inhibited in the naïve CD4 T cells that were incubated
with HCV+ Huh7.5 cells compared with cells co-cultured with HCV- Huh7.5 hepatocytes
(Fig.2.4B). In addition, T cells exposed to HCV-expressing hepatocytes were more apoptotic, as
demonstrated by a signiﬁcant increase (P=0.0357) in Av/7AAD expression in CD4 T cells
exposed to HCV compared with the negative control (data not shown).
We have previously shown that primary T cells treated with HCV core protein exhibited
a senescent state, as evidenced by a higher level of the aging marker β-Galactosidase expression
and shortened telomeres 5. To further investigate whether HCV core-treated T cells have
impairment in the DNA damage repair enzyme ATM, we exposed healthy naïve CD4 T cells to
HCV core protein, which is secreted by virally infected hepatocytes and circulates in the
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peripheral blood of HCV-infected patients and can dampen T cells through its interaction with
the globulin head of C1q receptor expressed on the surface of T cells, thus delivering inhibitory
signaling 29,. As shown in Fig.2.4C, compared to the β-gal control, treatment with HCV core
protein for 5 days significantly inhibited the phosphorylation of ATM, but not total ATM protein
in naïve CD4 T cells. In addition, HCV core-treated T cells exhibited an increased level of
γH2AX (a marker of DNA damage), suggesting that insufficient pATM is associated with an
increased DNA damage in HCV core-treated T cells.
ATM belongs to the PI3K family, and we have previously shown that HCV can induce T
cell senescence by inhibiting the AKT/PI3K pathway 3. To further explore the mechanisms that
might be involved in inhibiting ATM activation, we treated naïve CD4 T cells with LY294002 (a
potent PI3K-specific inhibitor) in the presence or absence of HCV core protein. As shown in
Fig.2.4D, compared with the DMSO-treated control, T cells treated with 20μM LY294002
exhibited remarkable inhibition of pATM, along with decreases in pAKT. Moreover, the cleaved
form of Poly (ADP-ribose) polymerase (PARP), an enzyme that catalyzes the transfer of ADPribose onto target proteins and plays an important role in DNA repair and cell survival, was
significantly increased in T cells treated with the PI3K inhibitor. In addition, we assessed the
effect of LY294002 on ATM inhibition in CD4 T cells co-cultured with HCV+/- Huh7.5 cells. As
shown in Fig.2.4E, pATM expression in CD4 T cells in the presence of Huh7.5 hepatocytes
without HCV infection was significantly inhibited by the PI3K inhibitor. pATM expression was
further inhibited in naïve CD4 T cells incubated with HCV+ Huh7.5 cells, especially in the
presence of PI3K inhibitor. These results suggest that HCV (core protein) can induce T cell DNA
damage that is associated with impaired ATM via inhibition of the PI3K.
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Fig.2.4. HCV inhibits ATM/pATM expressions via dampening PI3K pathway. A) HCV
infection of Huh7.5 hepatocytes. Immunostaining of HCV core protein is positive in HCVinfected cells, but negative in HCV-uninfected cells. B) ATM/pATM is inhibited in naïve CD4 T
cells co-cultured with Huh7.5 cells with HCV infection compared with those incubated with
Huh7.5 cells without HCV infection. C) HCV core protein inhibits ATM/pATM and enhances
γH2AX expressions in naïve CD4 T cells compared to the β-Gal control. D) PI3K inhibitor
(LY294002) inhibits pATM/pAKT and enhances PARP expressions in naïve CD4 T cells
compared to those treated with DMSO control. E) PI3K inhibitor (LY294002) inhibits pATM
expressions in naïve CD4 T cells co-cultured with HCV+/- Huh7.5 cells compared to the cells
without inhibitor treatment. Representative flow cytometry dot plots and summary data (n=8)
with p value between the groups are shown.
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Inhibition of ATM Phosphorylation in Naïve CD4 T cell Leads to DNA Damage and
Apoptosis
The ATM signaling pathway is pivotal to the maintenance of genome integrity and cell
survival 26. To test the functionality of this DNA repair machinery in T cell survival, freshly
isolated healthy naïve (CD4+CD45RO-) T cells were treated with a specific ATM inhibitor
(KU60019, 10μM) for 48 h, followed by measuring DNA damage and cell apoptosis or death. As
shown in Fig.2.5A, naïve T cells exposed to KU60019 showed an inhibition in ATM, in
particular pATM, compared with the DMSO control. In addition, the phosphorylation of CHK2
protein, a downstream effector of ATM signaling pathway, was significantly inhibited by the
treatment (Fig.2.5B). Importantly, T cells exposed to the ATM inhibitor exhibited an elevated
γH2AX expression, suggesting an increase in DNA damage (Fig.2.5C). In addition, T cells
treated with the ATM inhibitor exhibited an increase in DNA damage foci (γH2AX/53BP1 colocalization) compared with the control (Fig.2.5D). Moreover, ATM inhibition in naïve CD4 T
cells resulted in considerately increased T cell apoptosis and death, as demonstrated by an
increase in Av and 7ADD expression, as well as activated caspase-3 following treatment
(Fig.2.5E). In essence, an insufficiency of ATM leads to greater DNA damage and cell apoptotic
death, which may necessitate compensatory homeostatic proliferation and lead to telomere loss
and premature senescence, particularly in the naive T-cell pool, a mechanism that can potentially
contribute to the naïve T cell loss and poor immune (vaccine) responses in chronic HCV
infection.
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Fig.2.5. KU60019, an ATM inhibitor, induces DNA damage and cell apoptosis via inhibiting
ATM pathway. A) KU60019 inhibits ATM/pATM expressions in naive CD4 T cells.
Representative imaging and summary data show Western blot analysis for ATM/pATM
expressions in naïve CD4 T cells treated with 10 μM KU60019 or DMSO for 48 h. B) KU60019
inhibits CHK2/pCHK2 expressions in naïve CD4 T cells. C) KU60019 enhances γH2AX
expression in naïve CD4 T cells. (continued on the next page). D) KU60019 increases DNA
damage foci (γH2AX/53BP1 co-localization) in naïve CD4 T cells. E) KU60019 increases T cell
apoptosis in naïve CD4 T cells. Av, 7AAD, and active caspase-3 expressions are shown in naïve
CD4 T cells treated with KU60019 vs. DMSO control at 48 h.
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Fig.2.5. (Continued)

Reconstitution of ATM in HCV CD4 T Cells Repairs DNA Damage, Survival Defect, and
Cellular Functions
Given the critical role of ATM in repairing DNA-DSBs, we hypothesized that
reconstitution of ATM could protect HCV-derived T cells from DNA damage and restore the
signaling network required for repairing DNA breaks. To test this, we transfected CD4 T cells
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derived from HCV-infected individuals with Flag-His-ATM constructs or controls, including an
empty vector without ATM insert (Mock), and an ATM mutant (ATM-S1981A) in which the
serine (S) phosphorylation site at residue number 1981 was substituted by alanine (A), using the
Lonza transfection system. Despite high transfection efficiency (70%) with GFP transfection by
this system, ﬂuorescence-activated cell sorting analysis revealed intracellular His-ATM
expression in only 20-40% of the T cells transfected with Flag-His-ATM or control constructs
(Fig.2.6A). Western blotting confirmed an increase in ATM expression in the wild-type, as well
as mutant ATM-S1981A-transfected T cells (Fig.2.6B). Although ectopic overexpression of
ATM had broad biological consequences, we focused our investigation on the DNA repair, cell
survival, and cell function, by assessing γH2AX, caspase-3, and IL-2 expression levels as
readout. As shown in Fig.2.6C, compared to mock transfection, ATM reconstitution reduced
γH2AX expression after 48 h, whereas transfection of the non-phosphorylated form with an
ATM-S1981A mutant was unable to restore the level of DNA repair, indicating the importance
of ATM phosphorylation at serine 1981 in protecting cells from excessive DNA breaks. In
parallel, transfection of wildtype ATM significantly reduced T cell apoptosis, whereas mock- or
ATM-S1981A-transfected cells exhibited relatively higher levels of active caspase-3 expression
(Fig.2.6D), suggesting that ectopic ATM expression exerts immediate effects in determining T
cell fate by securing cell survival. Most importantly, implementing ATM significantly improved
T cell function, as shown by the increase in IL-2 expression in ATM-transfected cells, whereas
ATMS1981A transfection could not induce such an effect (Fig.2.6E). Taken together, these
results suggest that restoring an adequate ATM level in naïve CD4 T cells from chronic HCV
infection is sufficient to ameliorate DNA damage, survival defects, and cell dysfunctions.
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Fig.2.6. Ectopic ATM expression repairs DNA damage, cell apoptosis, and cellular
dysfunctions from HCV infection. A) Representative histogram of His Expression (Blue) in
Mock-, ATM, and ATM-S1981A-transfected naïve CD4 T cells derived from HCV-infected
patients. Isotype control (Red) was used for gating the His+ cells in flow cytometry analysis. B)
ATM expression in Mock, ATM, and ATM-S1981A-transfected naïve CD4 T cells from HCVinfected patients, measured by western blot. C) Representative dot plots and summary data of
flow cytometric analysis for the expression of γH2AX (n=10), active caspase-3 (n=9), and IL-2
(n=3) in Mock, ATM, and ATM-S1981A-transfected naïve CD4 T cells derived from HCVinfected patients.

Discussion
We and others have previously shown that T cells derived from patients with chronic
viral infections prematurely reach senescence, characterized by the shortening of telomeres and
expression of aging markers 2-6. In this study, we further demonstrate that homeostatic
remodeling of the T cell repertoire during HCV infection primarily affects the naïve T cell
compartment, characterized by an accumulation of DNA damage (owing to insufﬁcient
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activation) of the DNA repair ATM enzyme, which leads to naive T-cell apoptosis and loss.
Indeed, phosphorylation of ATM in T cells exposed to HCV (core protein) is inhibited through
dampening the PI3K pathway, resulting in an increase in DNA damage and cell apoptosis.
Moreover, pharmacological inhibition of ATM phosphorylation leads to more DNA damage and
apoptosis in naive T cells. Most importantly, reconstitution of ATM repairs the DNA damage,
cell apoptosis, and functional defects in naïve CD4 T cells derived from HCV-infected patients.
Based on these novel findings, we propose a model, depicted in Fig.2.7, where HCV-induced
ATM deficiency leads to accumulation of DNA damage and cell apoptosis. The excessive T cell
loss necessitates high homeostatic proliferation and imposes replicative stress on unprimed naïve
T cells; this represents a novel molecular mechanism underlying T cell senescence in the setting
of chronic viral infection. Importantly, ectopic overexpression of ATM is necessary and
sufficient to repair the DNA damage, survival defect, and cell dysfunctions in HCV-derived T
cells, thus providing a new strategy to improve immunotherapy and vaccine responses against
human viral diseases.
We and others have observed poor vaccine responses in the setting of chronic viral
(HCV, HIV) infections 2, 3, 15-19, but the underlying mechanisms for vaccine failure in virallyinfected individuals remain unclear. Data presented in this study indicate that naïve helper T
cells in chronically HCV-infected patients have abnormalities that jeopardize their ability to
mount effective immune (vaccine) responses. Specifically, we demonstrate that naïve CD4 T
cells have accumulation of damaged DNA and fail to repair their DNA-DSB owing to deficiency
of the ATM pathway. Accumulated DNA damage renders HCV-derived T cells prone to
apoptotic death, imposing replicative stress and premature aging on naïve T cell pools. These
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Fig.2.7. A novel model of HCV-induced ATM deficiency in T cell cycle arrest, DNA damage
repair, cell senescence, and apoptosis. HCV infection triggers a DNA damage response (DDR)
in the early phase via activation of MRN-ATM-CHK2 and P53 signaling pathways in naive CD4
T cells, prompting cell cycle arrest and allowing for DNA damage repair; or, if the infection is
overwhelming and causes unrepairable DNA damage, the cell will commit suicide and initiates
apoptosis. Persistent antigenic and inflammatory stimulation, however, drives ATM exhaustion
and insufficiency, leading to impaired DNA damage repair and accumulation of DNA DSB,
which results in constant cell apoptosis and naïve T cell loss. Excessive T cell loss necessitates
high homeostatic proliferation and imposes replicative stress on unprimed naïve T cells,
emerging as a novel molecular mechanism underlying T cell senescence in the setting chronic
viral infection. Importantly, ectopic overexpression of ATM is necessary and sufficient to repair
the DNA damage, survival deficit, and cellular dysfunction in HCV-derived T cells, providing a
new strategy to improve immunotherapy and vaccine responses against human viral diseases.
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findings are important because naïve T cells represent the reserve pool of the immune system,
and their survival critically determines the cellular yield of homeostatic proliferation, a process
that generates new T cells in response to neo-antigens, including vaccines.
Insufficient activation of ATM would be expected to affect both unprimed and primed T
cells. Indeed, we observed unrepaired DNA damage and cell apoptosis in both naive and
memory T-cell populations. However, ongoing antigenic stimulation during chronic viral
infection could drive naive T-cell differentiation and turnover of antigen-reactive T cells. In this
regard, memory T cells would expand and compromise the size and survival of naive T cells.
Eventually, the entire T-cell pool would be comprised by antigen-reactive T cells at the expense
of naive T cells. In the setting of chronic viral infection, however, memory T cells could be
functionally biased as a result of chronic antigenic stimulation; as such, we focused our studies
on the T-cell population that has yet to be recruited for immune responses. With the decrease in
newly generated naive thymic T cells in adults, chronic infection or inflammation might force
the immune system to restore equilibrium by replicating the available or existing naive T cells,
thereby driving telomere shortening and senescence in naive T-cell populations. Thus, the ability
to generate immune response to new antigens, such as HBV vaccine, could be compromised.
ATM has a unique role in lymphocyte biology, as programmed DNA damage repair is
part of the gene rearrangement necessary for formation of a highly diverse T cell receptor
repertoire. Under non-stress conditions, ATM is inactive and exists in the form of a dimer-(like
other PI3Ks). It requires a signal for activation (usually a DNA damage signal), signaling
through intermolecular autophosphorylation at ATM residue S1981, and resulting in the dimer
dissociation into monomers 31. In our study, a mutant of S1981A rendered ATM a dominantnegative protein, triggering more severe DNA damage (γH2AX expression), cell apoptotic death
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(Av/7AAD expression), and cellular dysfunction (IL-2 inhibition) - underscoring the importance
of ATM phosphorylation for its biological functions. ATM is predominantly localized in the
nucleus, and undergoes activation once the MRN complex senses and binds to DNA-DSB ends,
providing a platform for ATM recruitment and autophosphorylation 32, 33. Phosphorylation of
S1981 also stabilizes ATM at the damaged DNA sites and recruits more downstream effector
proteins to participate in the DDR 34. Among the multiple substrates phosphorylated by ATM is
the checkpoint kinase 2 (CHK2), which is phosphorylated at residue T62 following DSB
formation and prevents cells from progressing from G1 to S phase or, alternatively, leads to cell
apoptosis. The discovery of these DNA damage response proteins has shed light on the cellular
machinery that contributes to DNA repair and cell homeostasis.
Recently, Li et al. 35 identified prematurely aged T cells with damaged telomeres in
patients with rheumatoid arthritis resulting from defective activity of the DNA break sensor
MRE11A. In patients with chronic HCV infection, however, we find that the DNA damage
sensor MRN complex is intact in naïve T cells. Rather, the DNA damage repair enzyme ATM is
inhibited at a posttranscriptional level by HCV infection. Interestingly, Guo et al. 36, 37 reported
that ATM activation in response to ROS was independent of the MRN complex. ROS mediated
ATM signaling represses mTORC1 signaling and therefore cell growth and proliferation through
activation of TSC2 (a negative regulator of mTOR) by liver kinase B1 (also known as STK11)
and AMP-dependent protein kinases38. ATM engagement of the TSC2/ mTORC1 signaling
pathway can also regulate autophagy39, and differential localization of ATM is correlated with
activation of distinct downstream signaling pathways40. We have previously reported that T cells
treated with HCV core protein exhibit G1/S cell cycle arrest, which was associated with the
dysregulation of cell cycle regulatory proteins CDKs/Cyclins and P27kip1 41. Here, we
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demonstrate that concomitant with the insufficiency of ATM activation, the phosphorylation of
CHK2 is defective in naïve T cells from HCV-infected patients. Moreover, pharmacological
inhibition of ATM in healthy T cells also leads to a CHK2 defect, accompanied by a marked
increase in DNA damage and cell apoptosis - resembling the biological effects characteristic of
HCV-derived naive T cells. These results establish that in human T cells, CHK2 is targeted by
ATM and that the overall defect of this pathway can be attributed to ATM insufficiency due to
chronic HCV infection.
A typical feature of CD4 T cells in chronically HCV-infected patients is the shortening of
telomeres compared with age-matched healthy controls 5, 6. Several mechanisms may contribute
to this age associated loss of telomeres. Increased proliferative turnover can cause cell divisioninduced telomeres shortening. In addition, telomeric DNA is highly susceptible to DNA damage,
even more so than non-telomeric DNA. Plasmid-inserted human telomeres accumulate sevenfold
higher strand breakage than control sequences 42. Also, the frequency of single-strand breaks is
several-fold higher in telomeres than in the bulk genome when cells are treated with alkylating
agents or exposed to oxidative stress 43. In line with these findings, we have recently found that
the expression of the telomere shelterin TRF2 is significantly inhibited at the protein level in
naïve CD4 T cells derived from HCV-infected individuals, which renders the uncapped
telomeres prone to DNA damage (unpublished observations). Thus, telomere loss in HCV T cells
is triggered by DDR and the inability of timely repair by the ATM signaling pathway. In
addition, we have also discovered that KML001, a telomere-targeting drug, can induce telomeric
DNA damage and T cell apoptosis by impairing the ATM pathway (unpublished observations).
Notably, ATM is widely expressed in human T cells at an extremely high level to ensure
integrity of the genomic DNA in replicating lymphocytes. ATM activation represents the
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initiation of DDR, but its inhibition in persistently stimulated T cells indicates insufficiency of
this DNA repair enzyme and cell exhaustion and senescence in the setting of chronic viral
infection. This notion is supported by our observation in an in vitro stimulated T cell system that
ATM phosphorylation is increased in the early phase of KML001-treated T cells (3~6 h) and
decreased in persistently treated cells (24~48 h), along with increases in DNA damage, cell
apoptosis and functional impairment (unpublished observations).
In summary, accumulation of DNA damage and failure to repair the DNA-DSBs owing
to deficiency of the ATM-dependent DNA repair machinery during chronic viral infection may
have broader implications through impairing diverse cellular functions. As interferon (IFN)mediated T-cell apoptotic death has been well-studied in persistent viral infections 44-47, this
virus-induced DNA damage-mediated T-cell loss represents a new mechanism of immune
evasion. How HCV induces DNA-DSBs, and its relationship to the IFN-signaling pathway, are
under further investigation. As counteracting ATM deficiency may restore T-cell competency
during viral infection and prevent premature immune aging, these studies may provide new
strategies to improve immunotherapy and vaccine responses against human viral diseases.
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Supplement Data

Supplementary Figure S2.1 A) Flow cytometric analysis of Fas receptor expression on resting
naïve and memory CD4 T cells in PBMCs derived from HCV patients and HS. B) Confocal
microscopic analysis of 53BP1/γH2AX co-localization in memory CD4 T cells isolated from
HCV-infected patient and HS. Data were reproducible in cells derived from multiple subjects.
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Abstract
HIV infection leads to a phenomenon of inflammaging, in which chronic inflammation
induces an immune aged phenotype. Here, we investigated T cell homeostasis, telomeric DNA
damage and repair machineries in patients with virus-suppressed, latent HIV infection at risk for
inflammaging. We found a significant depletion in CD4 T cells, which was correlated with
apoptosis in latently HIV-infected individuals compared to age-matched healthy subjects (HS).
In addition, HIV CD4 T cells were prone to DNA damage that extended to chromosome ends
(telomeres), leading to accelerated telomere erosion - a hallmark of cell senescence.
Mechanistically, the DNA double-strand break (DSB) sensor MRE11, RDA50, and NBS1
(MRN) remained intact, but the DNA damage checkpoint kinase ataxia telangiectasia mutated
(ATM) and its downstream checkpoint kinase 2 (CHK2) were significantly suppressed in HIV T
cells. Consistently, ATM/CHK2 activation, DNA repair, and cellular functions were also
impaired in primary CD4 T cells following ATM knockdown or exposure to the ATM inhibitor
KU60019, as well as in a CD4 T cell line infected with HIV-1 in the presence of an integrase
inhibitor - raltegravir, which recapitulates the biological effects observed in HIV T cells in vivo.
Importantly, ectopic expression of ATM was essential and sufficient to reduce the DNA damage,
survival deficit, and cellular dysfunction in T cells from HIV-infected subjects. These results
demonstrate that failure of DSB repair due to ATM deficiency leads to increased DNA damage
and renders HIV T cells prone to senescence and apoptotic death, thus contributing to CD4 T cell
loss/dysfunction during latent HIV infection. Our study reveals a novel mechanism by which
ATM deficiency promotes T cell apoptosis/senescence, and provides a new therapeutic target for
inflammaging-induced immune dysfunction during chronic viral infection.
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Introduction
Aging is associated with, and may be caused by, low-grade inflammation - a
phenomenon known as inflammaging, which is a common denominator in the majority of agerelated diseases1-3. Inflammaging is a major driver of increased susceptibility to infections,
reduced responses to vaccines, increased incidences of cancers, cardiovascular diseases, and
neurodegeneration, all of which contribute to comorbidity and mortality in the elderly 1-3. In
human immune system, CD4 T cells are long-lived, and thus are exposed to extensive genomic
insults and replication pressure, making them vulnerable to aging-associated abnormalities.
Notably, the progressive loss of T cell proliferative capacity during the aging process directly
correlates with a gradually shortening of telomeres - a hallmark of cell senescence. Therefore,
telomere length has been deemed as a biological clock controlling cell aging, survival or
function, whereas telomere attrition has been considered as a faithful readout of inflammaging1-3.
Growing evidence suggests that this aging phenotype is recapitulated in chronic viral
infections 4, particularly in human immunodeficiency virus (HIV) infection, which is
characterized by disrupting CD4 T cell homeostasis and accelerating premature immune aging.
Many of the alterations that affect the immune system in HIV-infected individuals are
reminiscent of the course of inflammaging in the elderly 5, 6. Notably, antiretroviral therapy
(ART) does not always result in complete CD4 T cell recovery 7-10. Despite successful control of
HIV replication, residual inflammaging persists, leading to significant immune dysfunction.
Even with reasonable CD4 T cell numbers, ART-controlled individuals often experience a
profound inflammaging, characterized by extremely short telomeres, low IL-2 production, poor
cellular proliferation, and blunted vaccine responses 5-16. The inflammaging imposed by HIV
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exposes the immune system to unique challenges that lead to T cell exhaustion and senescence,
similar to that observed in the elderly. These alterations accelerate the decline of CD4 T cell
competency and thus define the overall immune dysfunctions during HIV latency. Therefore, the
virus-suppressed, latent HIV infection can be deemed as an excellent model of inflammaging in
humans, and it is thus important to elucidate the mechanisms underlying T cell senescence and
inflammaging that is characterized by telomere erosion in individuals with latent HIV infection.
Because DNA damage can cause telomere erosion, leading to premature cell senescence
and/or apoptosis 17, 18, we hypothesized that progressive CD4 T cell loss and failure of immune
recovery during latent HIV-1 infection could be, at least in part, due to a deficiency in the DNA
repair that alters telomere integrity. Indeed, we have previously shown that patients with chronic
hepatitis C virus (HCV) infection exhibit premature T cell aging, evidenced by overexpressed
aging markers and, particularly, shortened telomeres - indicative of excessive proliferative
turnover or inadequate telomeric maintenance 19, 20. Notably, in healthy primary T cells,
telomeres undergo shortening at a rate of 50-100 base pairs (bp) per cell division, and this
predictable loss of telomeric DNA with cell replication allows telomeres to serve as molecular
clock that controls the replicative capacity of human T cells before entering cell cycle arrest,
senescence, or apoptosis 21, 22. However, telomere loss can increase up to 250 bp per cell division
during viral infection and, in compensating for this, cell cycle arrest occurs when progressive
telomere loss reaches a critical point - known as senescence (a quiescent, non-replicative state
with decline in functional activities) 21, 22. Thus far, the precise mechanisms controlling telomeric
DNA damage, T cell homeostasis, inflammaging and immune senescence, however, remain
unclear.
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In this study, we investigated the molecular mechanisms that perturb T cell homeostasis
leading to inflammaging using a model of latent HIV infection in individuals on ART with
undetectable viremia, the state in which the majority of our HIV patients exist. We demonstrate
that deficiency of DNA damage checkpoint kinase ataxia telangiectasia mutated (ATM)
promotes DNA damage, telomere erosion, T cell senescence and apoptosis in virus-suppressed,
latent HIV infection. Specifically, we show that latent HIV infection is characterized by
telomeric DNA damage that remains unrepaired due to the ATM deficiency, leading to telomere
attrition, CD4 T cell senescence and apoptosis, a novel mechanism that controls T cell
homeostasis and premature immune aging. Thus, restoring the impaired ATM machinery may
provide a new strategy to improve T cell survival and functions during human viral diseases.

Materials and Methods
Ethics Statement
The study protocol was approved by the institutional review board (IRB) of East Tennessee
State University and James H. Quillen VA Medical Center (ETSU/VA IRB, Johnson City, TN).
All participants were adults and signed the informed consent form.

Subjects
The study subjects were composed of two populations: 150 latently HIV-infected
individuals and 166 age-matched HS. HIV subjects were virologically suppressed for HIV
replication with ART, as evidenced by undetectable level of HIV-RNA. Healthy subjects
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supplied by Physicians Plasma Alliance (Gray, TN) were negative for HBV, HCV, and HIV
infection.

Cell Isolation and Culture
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by Ficoll
density centrifugation (GE Heathcare, Piscataway, NJ). CD4+ T cells were isolated from PBMCs
using the CD4+ T Cell Negative Selection Kit (Miltenyi Biotec Inc., Auburn, CA). T cells were
cultured in RPMI 1640 medium containing 10% FBS (Atlanta Biologicals, Flowery Branch,
GA), 100 IU/ml penicillin and 2 mM L-glutamine (Thermo Scientific, Logan, Utah) at 37°C and
5% CO2 atmosphere. Cells were harvested at day 1 or day 4 in culture for detection of apoptosis
and DNA damage. To test the role of ATM activation in repairing DNA damage and apoptosis,
10 μM ATM inhibitor (KU60019, Abcam, Cambridge, MA) or DMSO were added to the
cultures at day 1, and the cells were collected after 48 h for measuring apoptosis and DNA
damage. To determine the role of the PI3K pathway in ATM activation, purified CD4 T cells
were cultured in the presence or absence of 20 μM PI3K inhibitor (LY294002, Sigma) for 48 h,
followed by flow cytometry or western blot analysis.

Flow Cytometry
For phenotypic analysis of CD4 T cells, PBMCs were stained with CD4-FITC, CD45RAPerCP710, CD57-APC (BioLegend, San Diego, CA), CD28-PE (Invitrogen, Carlsbad, CA),
PD1-FITC (eBioscience, San Diego, CA), or isotype control antibodies. To quantify cell
apoptosis, PBMCs were stained with CD4-A647 and CD45RA-FITC for naïve or memory cell
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populations. In some experiments, CD4 T cells were cultured for the indicated times, and then
stained with Annexin V-PE and 7-AAD using BD Pharmingen™ PE Annexin V Apoptosis
Detection Kit I (BD Biosciences, San Jose, CA). CD4+ T cells were also stained for caspase-3
expression following the protocol from CaspGLOW™ Fluorescein Active Caspase-3 Staining
Kit (Invitrogen). Levels of reactive oxygen species (ROS) in CD4 T cells were measured using
the DCFDA-based Cellular ROS Detection Kit (Abcam, Cambridge, MA) or CellROX Green
ROS Detection kit (ThermoFisher Scietific, Waltham, MA) according to manufacturer’s
protocol. For intracellular staining, the cells were fixed and permeabilized with Foxp3
Transcription Factor Staining Buffer Set (eBioscience), and stained with pATM (Ser1981)-PE
antibody (BioLegend), pCHK2 (Thr68)-PE antibody, γH2AX-PE (eBioscience), IL-2-PE , IFNγ-PE (Invitrogen), or KC57-FITC for HIV p24 (NIH-AIDS Reagent Program). Flow cytometry
was carried out as described previously 19, 20.

Flow-FISH
Telomere length was measured by a modified Flow-FISH method as described previously
20

. Briefly, PBMCs were stained with CD4-A647 and fixed with Cell Fixation buffer

(BioLegend) for 20 min. The cells were incubated with telomere probe TelC
(CCCTAACCCTAACCCTAA)-FITC (0.3µg probe/mL, PNA Bio,Newbury Park, CA) at room
temperature for 10 min in the dark, and then at 82 °C for 10 min. The cells were washed with
post-hybridization buffer, followed by flow cytometry buffer, and then stained with CD45RAperCP/Cy5.5 and analyzed by flow cytometry.
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RNA Isolation and Real-Time RT-PCR
Total RNA was extracted from 1 x 106 cells with PureLink RNA Mini Kit (Invitrogen),
and cDNA was synthesized using High Capacity cDNA Reverse Transcription Kit (Applied Bio
systems, Fostercity, CA) per the manufacturer’s instruction. Quantitative real-time PCR was
performed in triplicates using the following conditions: 95 °C 10 min and then 95°C, 15s; 60°C,
60s with 40 cycles. Gene expression was normalized to GAPDH and values are expressed as fold
changes using the 2-ΔΔct method. Primer sequences are shown in Table 3.1.

Western Blotting
Western blot was performed as described previously 19, 20, using pATM (Ser1981)
(D6H9), MRE11, RAD50, NBS1, PARP-1, pAKT, pCHK2 (Thr68) (C13C1), γH2AX (Cell
Signaling, Danvers, MA), p24 (NIH-AIDS Reagent Program), and β-Actin (8H10D10)
antibodies (Cell Signaling). Appropriate horseradish peroxide-conjugated secondary antibodies
(Cell Signaling) were used, and proteins were detected with the Amersham ECL Prime Western
Blotting Detection Reagent (GE Healthcare Bio-Sciences, Pittsburgh, PA). The blotted
membranes were stripped and re-probed with ATM (D2E2), AKT and CHK2 (D9C6) antibodies
(Cell Signaling). Protein bands were captured and quantified by Chemi DocTM MP Imaging
System (Bio-Rad System).

Confocal Microscopy
CD4+ T cells were isolated and cultured as described above, followed by
immunofluorescence staining using a method described previously 19, 20. Primary antibodies
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Table 3.1 Primer sequences to be used in the chapter 3
Genes to be amplified

Primer sequences

ATM

F: 5'-TGGATCCAGCTATTTGGTTTGA-3'
R: 5'-CCAAGTATGTAACCAACAATAGAAGAAGTAG-3'

MRE11A

F: 5'-CTTGTACGACTGCGAGTGGA-3'
R: 5'-TTCACCCATCCCTCTTTCTG-3'

RAD50

F: 5'-CTTGGATATGCGAGGACGAT-3'
R: 5'-CCAGAAGCTGGAAGTTACGC-3'

NBN

F: 5'-TTGGTTGCATGCTCTTCTTG-3'
R: 5'-GGCTGCTTCTTGGACTCAAC-3'

CHEK2

F: 5'-CCCAAGGCTCCTCCTCACA-3'
R: 5'-AGTGAGAGGACTGGCTGGAGTT-3'

TP53

F: 5'-TCAACAAGATGTTTTGCCAACTG-3'
R: 5'-ATGTGCTGTGACTGCTTGTAGATG-3'

GAPDH

F: 5'-TGCACCACCAACTGCCTTAGC-3'
R: 5'- GGCATGGACTGTGGTCATGAG-3'

HIV-1 specific primers

F: 5'-CAGATCCTGCATATAAGCAGCTG-3'
R: 5'- TTTTTTTTTTTTTTTTTTTTTTTTGAAGCAC-3'

included: rabbit anti-53BP1, anti-RAD51, anti-KU70 (Cell Signaling) and mouse anti-γH2AX
(Ser139) (Biolegend), or mouse anti-TRF1 (Thermo Fisher). Secondary antibodies included:
anti-rabbit IgG-Alexa Fluor 488 and anti-mouse IgG- Alexa Fluor 555 (Invitrogen). The cells
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were mounted with DAPI Fluoromount-G (SouthernBiotech, Birmingham, AL), and images
were acquired using a confocal laser-scanning inverted microscope (Leica Confocal, Model TCS
sp8, Germany).

HIV-1 Plasmid Transfection and Virus Infection
The pNL4-3 plasmid, which contains a full-length HIV-1 viral DNA inserted in pUC18
vector, was obtained from NIH AIDS Reagent Program (originated from Dr. Malcolm Martin) 23.
The NL4-3 mCherry Luciferase plasmid was a gift from Warner Greene (Addgene plasmid #
44965) 24, and was used as a positive control for transfection. About 20 µg of the HIV-1 and
HIV-1 mCherry plasmid were used for transfection of Human Embryonic Kidney 293 cell line
transformed with SV40 large T antigen (HEK293T) using the polyethylenimine (PEI) method 25.
Transfection efficiency and HIV-1 protein expression were confirmed by fluorescent microscopy
examination of mCherry, real-time RT-PCR detection of HIV-RNA, and ELISA (Abcam kit
#ab218268), or western blotting of p24. The supernatants of HIV-1-transfected 293T cells were
used to infect human Sup-T1 cells (NIH AIDS Reagent Program, cat# 100; originally from Dr.
Dharam Ablashi and was isolated from a 13-year old individual with Non-Hodgkin’s T cell
lymphoma) using the spinoculation method 25. Briefly, 1.5 x 106 Sup-T1 cells were infected with
supernatant containing 1~5 x 106 HIV-1 in culture plates using centrifugation at 1620 x g in a
37°C incubator. After 2 h of spinoculation, the supernatants were removed, to discard the
unattached viruses. Reltegravir (RAL, 66 mM, from NIH AIDS Reagent Program) was added to
some cultures as an antiretroviral drug. The media were changed every 3 days, and
approximately 1.5 x 106 were maintained at each passage with or without adding RAL. Cells
were harvested at days 3, 6, 9, 12 and 15 for flow cytometry, RT-PCR, and western blot analysis.
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ATM Silencing
Approximately, 1x 107 CD4 T cells were isolated from HS and transfected with 100 pmol
of ATM-specific SMARTpool siGENOME siRNAs or scramble siRNAs (Dharmacon, Lafayette,
CO) using the Human T Nucelofector Kit and Nucleofector I Device with program U-14 (Lonza,
Allendale, NJ). After 48 h, the cells were harvested and analyzed by flow cytometry, western
blot, and confocal microscopy.

ATM Overexpression
Purified CD4+ T cells from HIV patients were transfected with 2.5 µg of pcDNA3.1, or
pcDNA3.1(+)Flag-His-ATM wt, or human mutant ATM (S1981A; Addgene plasmids), using the
Human T Nucleofector Kit and Nucleofector I Device (Lonza, Allendale, NJ). After 48 h,
transfection efficiency was monitored by flow cytometry to measure the frequency of His+ cells.
Ectopic ATM expression was detected by western blot. Active caspase-3, γH2AX, and IL-2
expressions were assessed in the His-positive cells by Flow Cytometry.

Statistical Analysis
The data were analyzed using Prism 7 software and are presented as mean ± SEM or
median with interquartile range. Differences between two groups were analyzed by independent
Student's t test or Mann Whitney test, paired T test or Wilcoxon matched-pairs signed rank test.
Multiple groups were analyzed by one-way ANOVA test. P-values <0.05, <0.01, or <0.001 were
considered statistically significant or very significant, respectively.
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Results
CD4 T Cell Homeostasis and Apoptotic Susceptibility in Latently HIV-Infected Individuals
on ART
Dysregulated T cell homeostasis is a characteristic of chronic viral infections; however,
the precise mechanisms that control T cell homeostasis and virus persistence in humans remain
unclear 26. As an initial approach to identify factors that perturb T cell homeostasis in latent HIV
infection, we analyzed total (CD4+), naive (CD4+CD45RA+), and memory (CD4+CD45RA-) T
helper cell frequencies within PBMCs isolated from latently HIV-infected individuals on ART
with undetectable viremia (n=24) and age-matched HS (n=27). As shown in Fig.3.1A
(representative dot plots and summary data of flow cytometry), total CD4+ T cells (p<0.0001)
and naïve CD4 (p=0.0043), particularly memory CD4 T cell pools (p<0.0001), were
significantly contracted in latently HIV-infected individuals compared to HS. To determine
which subsets of memory CD4 T cells were most affected in latent HIV infection, we analyzed
the central memory (CD4+CD45RA-CCR7+CD28+), effector memory (CD4+CD45RA-CCR7CD28+/-), and terminally differentiated memory (CD4+CD45RA+CCR7-CD28-) T cells for this
patient group. We found that central memory CD4 T cell subsets were the most significantly
contracted during HIV latency (data not shown). This contraction of CD4 T cells, particularly
central memory CD4 T cell subsets, is consistent with previous studies 27, 28, which indicate a
state of immune activation followed by T cell exhaustion and senescence in patients with latent
HIV-1 infection.
The T cell repertoire in peripheral blood is well-maintained by a fine balance between
influx of newly generated T cells from the thymus, efflux by consumption via programmed cell
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death, and self-replication within the existing pool of lymphocytes. With deficient influx from
the thymus in adults, the immune system responds to challenges by expanding existing T cells,
leading to increased proliferative turnover, telomere erosion, and ultimately, cell apoptosis,
which represents a major mechanism for controlling peripheral T cell homeostasis in adults 29.
To explore how apoptosis contribute to T cell homeostasis during HIV latency, we compared the
Annexin V (Av) and 7-Aminoactinomycin D (7AAD) expressions in PBMCs derived from
latently HIV-infected individuals (n=8) and age-matched HS (n=8). As shown in Fig.3.1B
(representative dot plots and summary data of flow cytometry), Av/7AAD staining of CD4 T
cells showed increases in the rate of early apoptotic cell death in latently HIV-infected
individuals within the total CD4 (p=0.0050), as well as in naïve (p=0.0013) and, particularly,
memory CD4 T cells (p=0.0006). Importantly, apoptosis-prone CD4 T cells, particularly
memory CD4 T cells, appeared to be negatively correlated with their cell frequencies, analyzed
by Pearson Correlation (Fig.3.1C; n=8 per group; r=-0.4981, p=0.0496). Also, the flow
cytometry analysis of CD4 T cell frequencies faithfully correlated with the actual count of CD4
T cell numbers (Fig.3.1D; n=20; r=0.6039, p=0.0048), suggesting that CD4 T cell apoptosis
closely correlates with CD4 T cell loss during HIV infection. These results also indicate that the
apoptotic susceptibility of CD4 T cells in virus-suppressed, HIV-infected individuals may
necessitate compensatory homeostatic proliferation, leading to CD4 T cell exhaustion and
senescence.
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Fig.3.1. T cell homeostasis and apoptosis in HIV-infected patients versus age-matched HS.
A) PBMCs were isolated from 24 HIV-infected patients and 27 HS and analyzed for T cell
homeostasis by flow cytometry. Representative dot plots and summary data for percentages of
total CD4+, CD45RA+CD4+ (naïve), and CD45RA-CD4+ (memory) T cell frequencies are
shown. Each symbol represents an individual subject. The mean ± SE and p value are shown. B)
PBMCs isolated from 8 HIV-infected patients and 8 HS were analyzed for T cell apoptosis by
flow cytometry. Representative dot plots and summary data for percentages of Av and 7AAD
expression in total CD4+, CD45RA+CD4+ (naïve), and CD45RA-CD4+ (memory) T cells are
shown. Each symbol represents an individual subject. The mean ± SE and p value are shown. C)
Pearson analysis of the correlation between total or memory CD4 T cell frequencies and early
apoptotic cells in PBMCs isolated from HIV patients and HS. D) Pearson analysis of the
correlation between CD4 T cell frequencies and the actual CD4 T cell counts in HIV-infected
individuals.
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CD4 T Cell Exhaustion and Senescence in Latent HIV Infection
To determine the role of homeostatic proliferation in T cell exhaustion and senescence,
we first compared relevant markers on CD4 T cells isolated from latently HIV-infected
individuals versus age-matched HS. As shown in Fig.3.2A, the expression of programmed death1 (PD-1), a marker for cell exhaustion, was significantly upregulated on lymphocytes
(p=0.0055), as well as on CD4+ T cells (p=0.0231) in HIV patients compared to HS, though the
frequencies of PD-1+ CD4+ T cells in resting state were extremely low, whereas PD-1+ CD8+ T
cells were relatively high (data not shown), in the peripheral blood of both HIV and HS.
Since loss of CD28, a T cell receptor (TCR) co-stimulatory molecule required for T cell
activation and survival, is regarded as an unequivocal marker of T cell senescence 30, we
examined the CD28- populations within CD4+ T cells. As recently reported by the AGEhIV
Study Group 9, we observed a slight increase in the CD28- CD4+ T cells in latently HIV-infected
individuals; however, these increases were not significantly different (p=0.2829) compared to the
age-matched HS in our cohort (Fig.3.2B).
We have previously reported that CD57, also known as human natural killer 1 (HNK1)
that is expressed on the senescent NK or T lymphocytes 31, is highly expressed on CD4 T cells
derived from chronically HCV-infected individuals 20. We found that the percentage of CD57+
CD4+ T cell subsets was significantly increased in HIV patients versus HS (Fig.3.2C; p=0.0059).
This significant upregulation of CD57 expression was also observed in CD4 T cells isolated from
HIV and HS that were cultured in vitro for 3 days with or without TCR stimulation (n=12 per
group; p=0.0003 and p=0.0002, respectively), suggesting that HIV CD4 T cells are senescent.

77

Telomere Attrition and Telomeric DNA Damage in CD4 T Cells During Latent HIV
Infection
Telomeres are repeating hexameric sequences of DNA found at chromosome ends in
association with a complex of shelterin proteins. Telomere integrity is a key feature of linear
chromosomes that preserve genome stability and function, whereas telomere attrition is a
hallmark of cell aging or senescence that drives cell dysfunction or apoptosis 17, 18. Given the
importance of telomere attrition in cell senescence, we further investigated T cell aging in HIV
latency by measuring telomere length in total CD4+, CD4+CD45RA+ naïve and CD4+CD45RAmemory T cells by Flow-FISH. As shown in Fig.3.2D (representative plots for gating strategy
and pooled data of flow cytometry), telomere length was significantly shortened in HIV-derived
total CD4 T cells (p=0.0423) and, particularly, memory CD4 T cells (p=0.026), compared to agematched HS (n=24 per group). Most importantly, telomere length appeared to be inversely
correlated with the cell apoptotic rate in total, naïve and memory CD4 T cells from HIV and HS,
as determined by Pearson correlation (Fig.3.2D lower panel; n=8 per group; r=-0.3318,
p=0.0212), indicating that telomere erosion is associated with apoptosis of CD4 T cells in HIV
latency.
Since HIV replication is well-controlled by ART in our cohort, an important question is:
what drives telomere erosion and T cell apoptosis during latent HIV infection? We and others
have previously shown that naïve CD4 T cells are typically resistant to death receptor/ligand
(Fas/Fas-L)-mediated apoptosis 19, 20, 32, 33. Indeed, resting CD4 T cells typically do not express
Fas on their cell surface, and blocking the exogenous death pathways such as Fas-Fas ligand,
TNFα-TNF receptor, and TRAIL-TRAIL receptor interactions in CD4 T cells did not affect the
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KML001 (NaAsO2, an arsenic telomere targeting drug)-induced cell apoptosis (unpublished
observations), which points to cell internal signals as apoptosis initiators. Notably, one internal
stressor linked to cell apoptosis is damaged DNA, which is particularly prominent in senescent T
lymphocytes that have been chronically exposed to oxidative stress, such as endogenously
generated ROS 34.
To determine whether ROS might be an offender causing DNA damage and cell
apoptosis during latent HIV infection, CD4 T cells were isolated from latently HIV-infected
patients and HS, and cultured in vitro without stimulation for 1~4 days (to generate endogenous
ROS). Then ROS levels were measured by flow cytometry using the Cellular ROS Detection Kit
based on the absorption of cell permeable 2’,7’-dichloroflurescin diacetate (DCFDA), a
fluorogenic dye that measures hydroxyl, peroxyl and other ROS activity within the cell 35. As
shown in Fig.3.2E, the MFI of DCFDA was significantly increased in CD4 T cells derived from
HIV-infected patients compared to age-matched HS (n=10 per group; p=0.0939 at day 1 and
p=0.0035 at day 4 in culture, respectively). Interestingly, when these cells were cultured in vitro
without stimulation for 1~4 days, the MFI of DCFDAhigh cells remained high in HIV T cells,
whereas the percentage of DCFDAhigh cells decreased along with an increase in Av+ apoptotic
cells in HIV versus HS (data not shown). Because cell apoptosis can affect the DCFDA
measurement, we used another fluorescence-based method (CellROX Green) to measure ROS
production and assessed their relationship with apoptosis in cultured CD4 T cells derived from
HIV and HS for 4 days, and we found the same phenomena. As shown in Fig.3.2F, depending on
the levels of ROS and Av, CD4 T cells from both HIV and HS were gated into two major
populations: Av+ ROSlow and Av- ROShigh. Notably, in both HIV and HS, apoptotic dying cells
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(Av+) produced less ROS (MFI ROSlow), and live cells (Av-) produced more ROS (MFI
ROShigh). While the MFI of both Av- ROShigh and Av+ ROSlow subsets remained higher in HIV
than HS, the percentage (%) of Av- ROShigh cells was lower, whereas the % of Av+ ROSlow cells
was much higher, in HIV than HS. These data suggest that the intracellular ROS generated
during HIV infection may play an important role in triggering cell apoptosis, and the apoptotic,
dying cells produce less ROS.
Cells are equipped with DNA damage surveillance and repair machineries to prevent cell
death associated with genomic instability. Since mammalian telomeres consist of triple guanine
repeats (TTAGGG) that are very sensitive to oxidative DNA damage, particularly vulnerable to
ROS, we hypothesized that telomere sequences in HIV-derived T cells are not only shortened,
but more importantly, DNA damaged. Notably, following genotoxic insult, 53BP1 is recruited to
the DNA damage site on chromosomes (including telomeres), and acts as a docking site for other
mediator, transducer and DNA repair proteins to form microscopically visible nuclear foci (DNA
damage foci) 36. Thus, identifying damaged telomere induced foci (TIF) is typically considered
as a hallmark of telomeric DNA damage response (DDR) 37. To determine telomeric DDR in T
cells during latent HIV infection, we compared the number of TIFs per nucleus, as well as the
percentage of cells with > 3 TIFs, by examining co-localization of 53BP1/TRF1 using confocal
microscopy. As shown in Fig.3.2F (representative imaging and summary data), the number of
TIF per nucleus (p=0.0209) and the percentage of T cells with > 3 TIFs (p=0.0340) were
significantly higher in CD4 T cells derived from HIV patients compared to HS. Moreover, the
percentage (p=0.0383) as well as the mean fluorescence intensity (MFI) of phosphorylated
H2AX (γH2AX), a marker of DNA damage, were significantly upregulated in total (p=0.0192),
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naïve (p=0.0087) and memory (p=0.0148) CD4 T cells from HIV patients compared to HS, as
determined by flow cytometry (Fig.3.2G). These results suggest that telomeric DNA damage
may cause cell apoptosis and T cell loss in patients with latent HIV infection, emphasizing the
role of telomere integrity in securing T cell survival.

Fig.3.2. CD4 T cell exhaustion, senescence, telomere attrition and DNA damage in
latent HIV infection. A) Percentage of PD-1 expression on total lymphocytes (left panel)
and CD4 T cells isolated from HIV patients versus HS, as determined by flow cytometry
(n=number of subjects). B) Percentage of CD28- population in CD4 T cells from HIV
patients versus HS. Number of subjects examined (n) and p value are shown. C) Percentage
of CD57 expression on CD4 T cells from HIV patients versus HS. (continued on page 91)
D) Representative dot plots, histogram and summary data from 24 HIV patients and 24 HS
by Flow-FISH analysis of telomere length in total, naïve and memory CD4 T cells. Pearson
correlation analysis of the telomere length (MFI) and the percentage of early apoptotic cells
(Av+7AAD-) are shown below. . E) Flow cytometry analysis of the mean fluorescence
intensity (MFI) of DCFDA level in CD4 T cells isolated from PBMCs of 10 HIV patients
and 10 HS, and cultured in vitro without stimulation for 1~4 days. F) Flow cytometry
analysis for the percentage (%) and MFI of CellROX Green as well Av levels in cultured
CD4 T cells derived from HIV and HS for 4 days ex vivo. Representative dot plots and
summary data of the MFI as well as % of the two gated cell populations (AV- ROXhigh and
Av+ ROXlow) from three subjects in each group are shown. (continued on page 92) G)
Confocal microscopy analysis of 53BP1 and TRF1 co-localization in the nuclei of CD4 T
cells isolated from HIV patients versus HS. 100 cells were counted per subjects (n=number
of subjects examined). Summary data of dysfunctional telomere-induced foci (TIF) number
per nuclei, and the percentage of cells with > 3 TIFs in the two groups are shown. H)
Representative dot plots and summary data of the percentage of γH2AX expression in CD4
T cells (n=16 per group), as well as the MFI in total, naïve and memory CD4 T cells from
HIV patient versus HS (n=8 per group).
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Fig.3.2 (Continued)
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Fig.3.2 (Continued)
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ATM Expression and Activity Are Inhibited in CD4 T Cells During Latent HIV Infection
Accumulation of damaged DNA in CD4 T cells indicates that the DNA damage sensing
and repairing machinery are impaired during HIV infection. Essential components of this
machinery include DNA damage sensors, such as the MRE11, RAD50, and NBS1 (MRN)
complex, which recruits and mediates activation of DNA damage checkpoint kinase ATM that
can phosphorylate several downstream checkpoint proteins, including checkpoint kinase 2
(CHK2) and p53 38-40. To investigate the cellular machineries that promote the DNA damage
during HIV infection, we examined mRNA transcripts and protein expression of these DDR
proteins in CD4 T cells. As shown in Fig.3.3A, real-time RT-PCR analysis of the MRN
complex transcripts showed no alterations in the level of MRE11 (p=0.1830), RAD50
(p=0.7124), and NBS1 (p=0.7920). In parallel, the protein levels of these DNA damage sensors
in CD4 T cells remained unchanged in HIV patients and HS, detected by western blotting
(Fig.3.3B). Intriguingly, while the mRNA level of ATM was unchanged (p=0.2103, Fig.3.3C),
ATM protein level (p=0.0107) and phosphorylation on Ser1981 (p=0.0031), an indicative of its
activity, were significantly reduced and inhibited, respectively, in CD4 T cells from HIV patients
compared to HS (Fig.3.3D; representative imaging and summary data of western blotting). The
inhibition of ATM protein phosphorylation was confirmed by flow cytometry in total (p=0.006),
naïve (p=0.0254), and memory (p=0.0091) CD4 T cells from the studied subjects (Fig.3.3E).
Concurrently, while the mRNA levels of the ATM downstream signaling molecule CHK2 and
p53 remained unchanged (Fig.3.3F), phosphorylation of CHK2 (pCHK2), measured by flow
cytometry, was significantly inhibited in HIV T cells (Fig.3.3G). CHK2 inhibition, but not p53
expression, was also detected by western blot in HIV T cells compared to HS (Fig.3.3H).
Moreover, in line with the increased DNA damage and cell apoptosis in HIV T cells, the total
84

level of Poly ADP-Ribose Polymerase 1 (PARP-1, an apoptosis marker) 41 was decreased,
whereas the caspase 3-dependent cleaved PARP-1 was increased in HIV T cells. Taken together,
these results indicate that the DNA damage sensing machinery remains intact, but the protein
expression and activation of ATM/CHK2, two key components critically involved in repairing
DSB during DDR for cell survival, are significantly suppressed, at the post-transcriptional level,
during latent HIV infection.

Fig.3.3. DNA damage repair ATM signaling pathway in T cells of HIV-infected patients
versus HS.
A) MRE11, RAD50, and NBS1 mRNA expression, measured by real-time RT-PCR, in CD4 T
cells isolated from HIV-infected patients and age-matched HS (n=number of subjects to be
examined). B) Western blot showing MRN protein expression in CD4 T cells derived from HIV
patients versus HS. Representative imaging and summary data from 8 subjects in each group are
shown. (continued on the next page) C) ATM mRNA expression, measured by RT-PCR, in
CD4 T cells isolated from the study subjects (n=8 in each group). D) Western blot analysis of
ATM protein expression and phosphorylation in CD4 T cells derived from HIV patients versus
HS. Representative imaging and summary data from 16 subjects in each group are shown. E)
Flow cytometry analysis of pATM expression in total, naïve and memory CD4 T cells from 8
HIV patients versus 8 HS. F) CHK2 and p53 mRNA expressions, measured by RT-PCR, in CD4
T cells from 9 HIV patients and 9 HS. G) Flow cytometry analysis of pCHK2 expression in CD4
T cells from 8 HIV patients versus 8 HS. H) Western blot analysis of CHK2, p53, and cleaved
PARP-1 protein expressions in CD4 T cells derived from HIV patients versus HS.
Representative imaging and summary data from the indicated subjects in each group are shown.
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Fig.3.3 (Continued)
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ATM Protects T Cells from DNA Damage, Cell Apoptosis and Dysfunction via the PI3K
Pathway
The ATM signaling pathway is pivotal to the maintenance of genome integrity and cell
survival 42. To determine its role in T cell function and survival, we knocked down ATM
expression in healthy CD4 T cells using specific siRNAs, and measured cell apoptosis and
cytokine expression. As shown in Fig.3.4A, healthy CD4 T cells transfected with siRNA specific
to ATM (siATM) exhibited a significant decrease in ATM and pATM protein levels compared to
those treated with control siRNAs (siCON). Concurrently, CHK2 and pCHK2 expressions were
also diminished in ATM-silenced T cells. In addition, the frequencies of Av+ and caspase-3+
apoptotic cells were markedly increased, whereas the IFN-γ-producing CD4 T cells was
significantly decreased (Fig.3.4B) with the ATM knockdown.
To further investigate the role of ATM in maintaining T cell survival and normal
function, primary CD4 T cells isolated from HS were treated with a specific ATM inhibitor
(ATMi, KU60019) for 48 h, followed by measuring expression and activation of the
ATM/CHK2 pathway and cell apoptosis. As shown in Fig.3.4C, healthy CD4 T cells exposed to
KU60019 showed a marked decrease in the expression of ATM, in particular pATM, compared
to the DMSO-treated control. Concurrently, the levels of ATM downstream signaling molecule
CHK2, and particularly pCHK2, were significantly suppressed by this treatment. In addition, T
cells exposed to the ATMi exhibited an elevated level of cleaved PARP-1, suggesting increased
caspase 3-dependent, DNA damage-mediated cell apoptosis.
Since ATM belongs to the phosphoinositide 3-kinase (PI3K) family, which plays a key
role in cell survival and function 42, 43, we examined whether the expression and activation of
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AKT could be suppressed by the ATM inhibition. As shown in Fig.3.4C, both AKT and pAKT
were inhibited in CD4 T cells exposed to the KU60019 treatment. Conversely, we also examined
whether ATM expression and activation could be blocked by the PI3K inhibitor (PI3Ki). To this
end, we incubated CD4 T cells with or without the PI3Ki (LY294002) for 48 h, followed by
examination of ATM/pATM, CHK2/pCHK2, AKT/pAKT, as well as cleaved PARP-1
expressions by western blot. As shown in Fig.3.4D, compared to the DMSO control, T cells
treated with 20 μM of LY294002 exhibited a significant inhibition of ATM/pATM and
CHK2/pCHK2 expressions, along with suppression of AKT/pAKT levels, and an increase in the
level of cleaved PARP-1. These results indicate that ATM deficiency is mediated via inhibition
of the PI3K pathway.

The NHEJ Pathway Is Involved in the ATM-Mediated DNA Repair and Telomere
Maintenance
We next examined the role of ATM in protecting T cells from DNA damage, and found
that T cells treated with the ATMi exhibited an increase in the expression of γH2AX, a marker
for DNA damage (Fig.3.4E). These T cells also had increases in DNA damage foci
(γH2AX/53BP1 co-localization), measured by confocal microscopy (Fig.3.4F). It is well-known
that Ku70 and Ku80 make up the Ku heterodimer, which bind to DSB ends and is required for
the non-homologous end joining (NHEJ) pathway of DNA repair. It is also required for V(D)J
recombination, which utilizes the NHEJ pathway to promote antigen diversity in the mammalian
immune system. In addition to its role in NHEJ, Ku is involved in telomere maintenance 44. It has
been reported that mutant mice deficient Ku70 exhibit premature aging 45, suggesting that Ku70
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plays an important role in longevity assurance and that reduced ability to repair DSB or maintain
telomere integrity causes early aging. To determine the role of ATM in Ku70-mediated telomeric
DNA damage repair, we measured the Ku70-dependent, damaged telomere induced foci (TIF) in
CD4 T cells exposed to ATMi for 48 h by confocal microscopy. As shown in Fig.3.4G,
Ku70/TRF1-formed TIFs were clearly found increased in cells treated with the ATMi compared
to the DMSO control. We also examined possible involvement of the ATM pathway in
homologous recombination (HR) of DNA during DSB repair. Since RAD51 is involved in the
search for homology and strand pairing process 46, 47, we used confocal microscopy analysis for
the RAD51/TRF1-dependent TIF in CD4 T cells exposed to ATMi or DMSO for 48 h, but found
no significant difference between the two treatments (Fig3.4H). These results suggest that the
NHEJ, rather than the HR, pathway appear to be involved in the ATM-mediated telomeric DNA
repair.
Moreover, we examined the role of ATM in protecting T cells from cell apoptosis and
cellular dysfunction. We demonstrated that ATM inhibition in CD4 T cells increased T cell
apoptotic death, and HIV T cells appeared to be more vulnerable to the ATMi-mediated
apoptosis, as evidenced by the higher baseline and the slope of increase in Av/7ADD (Fig.3.4I),
as well as caspase-3 expressions (Fig.3.4J) in CD4 T cells derived from HIV patients versus HS.
Meanwhile, these ATMi-treated CD4 T cells exhibited diminished IL-2 (Fig.3.4K) and IFN-γ
(Fig.3.4L) expressions compared to the controls. Taken together, these results demonstrate that
ATM inhibition can lead to increased DNA damage, cell apoptosis, and cell dysfunction, which
potentially contribute to the CD4 T cell loss and poor immune responses observed in latent HIV
infection.
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Fig.3.4. ATM plays a key role in protecting T cells from DNA damage, cell apoptosis and
cellular dysfunction. A) Western blot analysis of ATM, pATM, CHK2, and pCHK2 expressions
in CD4 T cells transfected with ATM siRNA (siATM) or control siRNA (siCON).
Representative imaging from repeated experiments is shown. B) Apoptosis and functional assays
of CD4 T cells with ATM knockdown. Representative dot plots and summary of the percentage
of Av (n=7), caspase-3 (n=7), and IFN-γ (n=4) expressions in CD4 T cells transfected with
siATM or siCON. C) Western blot analysis of ATM, pATM, CHK2, pCHK2, cleaved PARP-1,
AKT, and pAKT expressions in CD4 T cells treated with the ATM inhibitor (KU60019) or
DMSO control for 48 h. D) Western blot analysis of ATM, pATM, CHK2, pCHK2, AKT,
pAKT, and cleaved PARP-1 expressions in CD4 T cells treated with the PI3K inhibitor
(LY294002) or DMSO control for 48 h. Representative imaging from repeated experiments is
shown. E) Flow cytometry analysis for the MFI of γH2AX expression in CD4 T cells treated
with KU60019 or DMSO for 48 h. (continued on page 100) F-H) Representative imaging of
confocal microscopy examination of co-localization of 53BP1 and γH2AX, Ku70 and TRF1,
RAD51 and TRF1, in CD4 T cells treated with KU60019 or DMSO for 48 h (n=6). I-J) Flow
cytometry analysis of Av% and caspase-3% in CD4 T cells from HIV and HS exposed to
KU60019 or DMSO for 48 h. (continued on page 101) I-J) Flow cytometry analysis of Av%
and caspase-3% in CD4 T cells from HIV and HS exposed to KU60019 or DMSO for 48 h. K-L)
Representative dot plots and summary data of IL-2 and IFN-γ productions in healthy CD4 T cells
stimulated with PMA and inomycin in the presence of KU60019 or DMSO for 48 h.
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Fig.3.4 (Continued)
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Fig.3.4 (Continued)
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HIV Infection of CD4 T Cells in Vitro Promotes Telomere Loss and Cell Apoptosis
Because chronically HIV-infected patients often have co-morbidities that may contribute
to immune dysregulation, we sought to examine the role of HIV infection in promoting telomere
loss and CD4 T cell apoptosis without cofounding factors. To this end, we established an in vitro
HIV-1 cell culture system by employing a pNL4-3 plasmid that contains a full-length HIV-1
viral genome 23. A NL4-3 mCherry Luciferase plasmid was used as a positive control for cell
transfection 24. Successful transfection of HEK293T cells was confirmed by fluorescence
microscopy to examine HIV-1 mCherry cassette in red color, whereas mock transfected cells
show negative fluorescence signal (Fig.3.5A). HIV-RNA and p24 antigen were detected in the
supernatant of transfected 293T cells by real-time RT-PCR and ELISA (data not shown). Since
0.1 ng/ml p24 protein is equivalent to 1 x 106 HIV-1 virus particles 48, culture supernatants
containing 1~5 x 106 HIV-1 virions were employed to infect 1.5 x 106 human Sup-T1 CD4 T
cells using the spinoculation method 25. As shown in Fig.3.5B, p24 antigen was detected in HIV1-infected Sup-T1 cells by flow cytometry, with p24+ cells increase in a time-dependent manner.
Also, HIV-RNA and p24 protein were found in the supernatants of HIV-1-infected Sup-T1 cells,
but not in the supernatants of uninfected cells, measured by RT-PCR and ELISA (data not
shown). To mimic the clinical settings of HIV-infected patients on ART, we added 66 nM of
RAL, an integrase inhibitor, after 2 h spinoculation infection. As shown in Fig.3.5C, HIV-RNA
detection remained negative in uninfected Sup-T1 cells, but was positive in HIV-1-infected cells
(lane 2, 6 at day 3, 6 after infection), and was undetectable in HIV-1-infected cells treated with
RAL, as well as in uninfected cells in the presence of RAL. These results demonstrate that SupT1 cells can be infected by HIV-1 and that RAL potently inhibits HIV-1 replication. Thus this
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cell culture system represents an in vitro model mimicking the active and suppressed HIV
infection on ART in vivo.
We then asked whether HIV infection in vitro, with or without RAL treatment, can cause
T cell apoptotic death. Interestingly, T cell apoptosis, measured by the Av/7AAD expression,
was not observed in the early phase (1~3 days) of HIV infection, and apoptotic death was
measured at 6 days after HIV-1 infection (representative dot plots of Av and 7AAD expression
in Sup-T1 cells, with or without HIV-1 infection and RAL treatment; and summary data of Av+
7AAD- early apoptotic cells as well as Av+ 7AAD+ late apoptotic cells at day 3, day 6, and day 9
after infection were shown in Fig.3.5D). Notably, uninfected Sup-T1 cells cultured for 6 days
showed baseline levels of early apoptotic (Av+7AAD-, 10.0%) and late apoptotic (Av+7AAD+,
2.6%) cells. Low (1 x 106 virions) ~ high (5 x 106 virions) concentrations of HIV-1 infection
increased the number of early apoptotic (Av+7AAD-, 23.4 ~ 36.5%) and late apoptotic
(AV+7AAD+, 9.1 ~ 23.3%) cells in an infection dose-dependent manner. The presence of RAL
had no effect on apoptotic death in uninfected cells (early and late apoptotic cells were 9.5% and
2.9%, respectively). However, compared to the infected cells without RAL, RAL treatment
significantly reduced HIV-1-induced cell apoptotic death, as evidenced by remarkable decreases
in the Av+7AAD+ late apoptotic cells from 9.1 ~ 23.3% to 3.3 ~ 2.2%, and the Av+7AAD- early
apoptotic cells reduced from 23.4 ~ 36.5% to 9.9 ~ 17.5% at day 6 after infection. We also
observed the same trend at day 9 after HIV-1 infection, i.e., RAL treatment significantly reduced
the Av+7AAD+ late apoptotic cells from 43.2 ~ 47.1% to 2.4 ~ 1.9%, but the Av+7AAD- early
apoptotic cells remained high (39.9 ~ 46.3% and 36.0 ~ 42.7%, respectively) in an HIV-1 dosedependent manner in the absence or presence of RAL treatment.
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In parallel, we also counted the actual cell numbers with or without HIV-1 infection
and/or RAL treatment. To this end, Sup-T1 cells were cultured with 1.5 x 106 cells/3 ml on day 0
of HIV-1 infection. The cells were counted every 3 days and then seeded with 1.5 x 106 cells/3
ml per well at each passage. As shown in Fig.3.5E, the number of Sup-T1 cells increased rapidly
in the uninfected group, and HIV-1 infection clearly reduced the cell proliferation and killed the
cells in a virus dose- and time-dependent manner. However, no such effects were observed in the
RAL-treated cells. These data support the Av/7AAD assay results showing that RAL can reduce
the cell death of HIV-1 infected cells, although they remain in an early apoptotic state
(Fig.3.5D). These results are also in line with a previous report showing that HIV-1 can induce
formation of syncytia that kill CD4 lymphocytes 49.
We next asked whether HIV-1-induced T cell apoptosis is related to the DNA damage at
telomeres. We used Flow-FISH to measure the telomere length in Sup-T1 cells with or without
HIV-1 infection. As shown in Fig.3.5F (representative overlaid histogram and summary data
from 3 independent experiments), T cells infected with HIV-1 at 3 days, and particularly, at 6
days showed a significantly shortened telomere length compared to uninfected cells (P=0.0148
and P=0.0288, respectively). These results are in line with the observations of shortened
telomere in CD4 T cells derived from HIV-infected patients (Fig.3.2D), indicating that telomere
erosion is associated with cell apoptosis in HIV infection.

ATM Is Dysregulated in HIV-Infected T cells in Vitro, which Promotes DDR and Cell
Apoptosis.
To determine whether telomeric DNA damage and cell apoptosis is associated with the
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ATM alteration induced by HIV-1 infection, we measured ATM, CHK2, and AKT expressions,
along with the DNA damage marker γH2AX and apoptosis marker PARP-1, in Sup-T1 cells with
varying concentrations of HIV-1 or without infection for 3~6 days. As shown in Fig.3.5G,
kinetic measuring of p24 expression in Sup-T1 cells by western blot showed HIV-1 infection in a
virus dose- and time-dependent manner. Interestingly, the amount of ATM and its downstream
signaling kinase CHK2 were increased in the early phase (day 3) and then decreased in the late
phase (day 6) of HIV-1 infection. Also, the level of PI3K/AKT showed the same trend as the
ATM/CHK2 alteration. Correspondingly, the γH2AX and caspase 3-dependent cleavage of
PARP-1, which plays an important role in DNA damage-mediated cell apoptosis 39, was
increased at day 6, but not at day 3 that has no apoptosis detectable yet, after HIV-1 infection.
Based on these observations, we chose the day 6 time-point after HIV-1 infection, with or
without RAL treatment, to get more insight into the role of the ATM pathway that is critically
involved in the DDR and DSB repair during viral infection. As shown in Fig.3.5H, p24 was only
detected in HIV-1-infected Sup-T1 cells, but not in uninfected or HIV-1-infected + treated with
RAL. Intriguingly, compared to the uninfected control (lane 1), HIV-infected cells (lane 2)
exhibited a slightly inhibited ATM, but pATM was increased, likely reflecting HIV-1-induced
DDR. In parallel, CHK2 and AKT were inhibited, but pCHK2 and pAKT were significantly
upregulated by the HIV-1 infection, along with upregulation of DDR-mediated apoptotic
markers, such as γH2AX and PARP-1. Interestingly, RAL treatment alone (lane 3) did not
significantly alter the ATM, pATM, CHK2, pCHK2, AKT, pAKT, γH2AX, and PARP-1 levels
in Sup-T1 cells when compared to the uninfected cells without RAL treatment (lane 1).
However, RAL treatment of HIV-1-infected cells (lane 4) inhibited p24 expression and resulted
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in lower expression levels of ATM/pATM, CHK2/pCHK2, and AKT/pAKT. We also found
similar inhibition of ATM/pATM, CHK2/pCHK2, and AKT/pAKT expressions in Sup-T1 cells
at day 12 after HIV-1 infection and RAL treatment (data not shown), which recapitulated the
findings in patients with latent HIV-1 infection on ART. Taken together, these results suggest
that the ATM signaling pathway is dysregulated in CD4 T cells by HIV-1 infection that is
associated with the DDR-mediated cell apoptosis.

Fig.3.5. Mechanisms involved in inhibition of ATM expression and activation. A)
Fluorescence microscopy examination of 293T cells transfected with no plasmid (mock) or HIV1 mCherry plasmid for 48 h. B) Representative dot plots of flow cytometry analysis of HIV-1
p24 antigen expression in Sup-T1 cells (CD4 T lymphoblast isolated from a 13 year old
individual with Non-Hodgkin’s T cell lymphoma) with or without HIV-1 infection for 3 and 6
days. C) RT-PCR detection of HIV-RNA in Sup-T1 cells with or without HIV-1 infection and
RAL treatment for 3 and 6 days. (continued on the next page) D) Flow cytometry analysis of
apoptosis in Sup-T1 cells with escalating concentrations of HIV-1 inoculation dose.
Representative dot plots and summary data of early (Av+ 7AAD-) as well as late (Av+ 7AAD+)
apoptotic cells at different time point (3, 6, 9 days) after HIV-1 infection with or without RAL
treatment are shown. E) Cell number counts of Sup-T1 cells infected with HIV-1 and treated
with or without RAL for different time points (0, 3, 6, 9 days after HIV-1 infection). F)
Representative overlaid histogram and summary data of Flow-FISH analysis for telomere length
in Sup-T1 cells infected with or without HIV-1 at 3 and 6 days. The data are summarized from
three repeated experiments, and telomere length (MFI) in HIV-infected cells are normalized by
those in uninfected cells. G) Western blot analysis of p24, ATM, CHK2, AKT, γH2AX, and
PARP-1 expressions in Sup-T1 cells infected with escalating concentrations of HIV-1 for
different time points (3 and 6 days). H) Western blot analysis of p24, ATM, pATM, CHK2,
pCHK2, AKT, pAKT, γH2AX, and cleaved PARP-1 expressions in Sup-T1 cells with or without
HIV-1 infection and RAL treatment for 6 days.
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Fig.3.5 (Continued)
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Reconstitution of ATM in HIV CD4 T Cells Reduces DNA Damage, Survival Defects, and
Cellular Dysfunctions
Given the critical role of ATM in repairing DNA damage, we hypothesized that
reconstitution of ATM could recover HIV T cells from DNA damage and restore the signaling
network required for repairing DNA-DSB. To test this, we transfected CD4 T cells derived from
HIV-infected, ART-treated individuals with Flag-His-ATM expression construct or control
plasmids, an empty vector without ATM insert (Mock) and an ATM kinase-dead mutant (ATMS1981A) in which the serine residue at 1981 was substituted by an alanine residue. As shown in
Fig.3.6A, western blot analysis confirmed the increases in ATM and pATM expressions in the
ATM-transfected T cells compared to the control. Additionally, protein expression and
phosphorylation (pCHK2) of the ATM downstream signaling molecule CHK2 were increased in
ATM-transfected cells (Fig.3.6B). Although ectopic overexpression of ATM could have broad
biological consequences, we focused our investigation on DNA repair, cell survival, and cell
function by assessing PARP-1, caspase-3, γH2AX, IL-2, and IFN-γ expressions as readouts.
Specifically, the caspase-3-dependent cleavage of PARP-1 was decreased in T cells transfected
with the wild-type ATM, but not the ATM kinase-dead mutant (Fig.3.6C). Concurrently, level of
the active form of caspase-3 was reduced in T cells with ATM reconstitution, but not with the
ATM-S1981A transfection, though such decrease was not significant (data not shown).
Compared to the mock transfection, overexpression of ATM significantly reduced γH2AX level
in transfected (His+) CD4 T cells, whereas transfection of the ATM-S1981A mutant did not elicit
such an effect, indicating the importance of ATM kinase activity in protecting cells from
excessive DNA damage (Fig.3.6D). These results are in line with the data showing that
transfection of wild-type ATM significantly reduced cleaved PARP-1, whereas mock- or ATM99

S1981A-transfected cells exhibited relatively higher levels of cleaved PARP-1 (Fig.3.6C). Thus,
these results suggest that ectopic ATM expression exerts immediate effects on repairing DNA
damage and regulating T cell fate to secure cell survival. Importantly, reconstituting ATM
eventually restored T cell function, as demonstrated by the significant increase in IL-2 (Fig.3.6E)
and the partial recovery of IFN-γ expression (Fig.3.6F) in ATM-transfected cells, whereas
ATM-S1981A transfection could not induce such an effect. Taken together, these results
demonstrate that restoring an adequate wild-type ATM level in CD4 T cells from latent HIV
infection is necessary and sufficient to reduce the DNA damage, survival defects, and cell
dysfunctions.

Fig.3.6. Ectopic expression of ATM reduces DNA damage, cell apoptosis and dysfunction of
CD4 T cells from HIV patients. A-C) Western blot analysis of ATM/pATM, CHK2/pCHK2,
and cleaved PARP-1 expressions in CD4 T cells derived from HIV-infected patients with or
without ATM overexpression (n=9). (continued on the next page) D~F) Representative dot
plots and summary data of flow cytometry analysis of the expression of γH2AX (n=4), IL-2
(n=5) and IFN-γ (n=5) in Mock, ATM, and ATM-S1981A-transfected (His+) CD4 T cells
derived from HIV-infected patients. P values between each group are shown.
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Fig.3.6 (Continued)

Discussion
T cells play a pivotal role in controlling viral infection and vaccine responses. However,
the mechanisms that dysregulate T cell functions during viral infections, particularly in latent
phase, remain incompletely understood. In this study, we investigated the mechanisms that
101

perturb T cell homeostasis, apoptosis, DNA damage and repair machineries in CD4 T cells from
patients with virus-suppressed, latent HIV infection. We found a significant depletion of CD4 T
cells, which was inversely correlated with cell apoptosis in HIV-infected individuals.
Additionally, HIV-derived T cells exhibited accumulation of DNA damage that extended to
telomeres, leading to accelerated telomere attrition. Mechanistically, the DNA damage sensor
MRN complex remained intact, but the expression and activation of PI3K family member ATM
and its downstream checkpoint kinase CHK2 were significantly suppressed in HIV T cells.
Consistently, ATM/CHK2 activation and cellular functions were impaired in primary healthy
CD4 T cells following ATM silencing, or exposure to an ATM inhibitor, and also in a CD4 T
cell line infected with HIV-1 in the presence of RAL, which recapitulates the biological effects
we observed in vivo in HIV-infected patients on ART. Importantly, ectopic expression of ATM
was essential and sufficient to reduce the DNA damage, survival deficit, and cell dysfunctions in
HIV-derived T cells. These results demonstrate that ATM deficiency may lead to accumulation
of telomeric DNA damage, rendering CD4 T cells prone to apoptosis in the setting of latent HIV
infection. Based on these novel findings, we propose a model, as depicted in Fig.3.7, in which
HIV infection-induced ATM deficiency drives accumulation of telomeric DNA damage,
premature T cell senescence, and apoptosis. This constant, excessive CD4 T cell depletion would
necessitate high homeostatic proliferation and impose replicative stress on naïve and particularly
memory CD4 T cells, leading to further cell senescence or apoptosis - a malicious cycle for CD4
T cell dysregulation during chronic HIV infection.
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Fig.3.7. A working model depicting the role of HIV-induced ATM deficiency in T cell cycle
arrest, telomeric DNA damage, cell senescence, and apoptosis. HIV infection triggers a DNA
damage response (DDR) during the early phase of infection via the activation of MRN-ATMCHK2/P53 signaling pathways in CD4 T cells, prompting cell cycle arrest (through the p21/p27regulated CDK/Cyclins) and allowing DNA damage repair. If the infection persists and causes
unrepairable DNA damage, the cell will commit suicide and undergo apoptosis. Persistent
antigenic and inflammatory or ROS stimulation in the setting of latent HIV-1 infection in
individuals on ART, however, drives T cell exhaustion (PD-1) and senescence (telomere
attrition) by inducing ATM (PI3K-like kinase) deficiency (low protein expression and
phosphorylation, likely via a miRNA181-mediated DUSP6/SIRT1 dysregulation), leading to
inflammaging and impaired DNA damage repair, which results in constant DNA damage
(γH2AX, 53BP1 accumulation), cell apoptosis (caspase-3-dependent cleavage of PARP-1), and
thus CD4 T cell loss. Excessive CD4 T cell loss necessitates high homeostatic proliferation and
imposes replicative stress on reactive memory CD4 T cells and unprimed naïve T cells, leading
to accelerated, premature T cell aging or senescence. This represents a novel molecular
mechanism underlying the T cell dysfunction and immune (vaccine) non-responsiveness seen in
the setting of latent HIV infection.
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The mechanisms underlying inflammaging development in ART-controlled, latent HIV
infection remain elusive, but multiple factors may be involved. Specifically, HIV latency in the
era of ART is characterized by the existence of viral reservoirs that prevent HIV-1 eradication
and likely drive inflammaging 50, 51. Thus, HIV-mediated inflammaging could result from a
myriad of insults, such as viral particles or viral proteins released from the reservoirs, cellsecreted pro-inflammatory mediators, HIV-enhanced gut permeability and altered gut microbiota
or dysbiosis, frequent cytomegalovirus (CMV), Epstein–Barr virus (EBV), and HCV
coinfections, ART regimens, as well as other closely associated comorbidities including
malignancies, or even social, personal stresses and environmental factors 52-55. As demonstrated
in this study, ROS generated within the cellular milieu during viral infection might also drive
inflammaging.
This residual chronic, low-grade inflammation-mediated inflammaging during latent HIV
infection appears to trigger immune activation that may increase the risk of developing
comorbidities, similar to those observed in the elderly. For example, individuals living with HIV
have accentuated risks for age-associated comorbidities; a 2-fold higher risk of cardiovascular
disease, a 3-fold increased risk of fracture, and a risk of developing kidney disease that is
comparable to those with diabetes 8. Some comorbidities may present at younger ages compared
to the general population, suggesting an accelerated, premature aging in the setting of wellcontrolled but latent HIV infection 56.
An important question is why and how do CD4 T cells accumulate DNA damage and fail
to repair telomere defects during HIV infection? Human CD4 T cells have a relatively long life
span (~150~160 days) and thus are exposed to a multitude of genotoxic stresses, leading to ~1%
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out of a pool of 300 billion T cells to be replaced daily 29. To maintain genomic stability and cell
survival, cells continuously recognize and respond to DNA damage by either activation of DNA
damage checkpoints to arrest cell cycle progression and allow for repair, or, if the damaged DNA
is beyond repair, to undergo apoptosis 38. Notably, a major sensor of DSB is the MRN complex,
which subsequently recruits the protein kinase ATM, an enzyme critically involved in repairing
DNA damage for cell survival 39, 40. Our results revealed that while the MRN complex was
intact, ATM was dramatically affected by HIV even in the setting of a robust viral suppression in
both in vitro and in vivo models, and was associated with significant DNA damage at telomeres.
Accumulation of damaged DNA activates the ATM cascades, along with ataxia telangiectasia
Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit c (DNA-PKc), which
all belong to the PI3K-related kinase (PIKK) family and are important for DNA reprogramming
and T cell rearrangement 42, 43.
ATM was originally identified in individuals with ataxia telangiectasis (AT), an
autosomal recessive disorder that manifests with progressive ataxia, telangiectasia,
immunodeficiency, genomic instability, and cancer predisposition 57. It is a key kinase within the
DDR signaling cascade 42, 43, and plays a unique role in lymphocyte biology, as programmed
DDR participates in the gene remodeling process necessary for formation of a highly diverse
TCR repertoire. ATM requires a signal for activation (usually a DNA damage signal), which
promotes intermolecular auto-phosphorylation at ATM residue at serine 1981, resulting in its
inactive dimer dissociation into active monomers 58. In the current study, a mutant of S1981A
rendered ATM a dominant-negative protein and triggered distinct DNA damage-mediated cell
apoptosis and cellular dysfunction (IL-2 inhibition), which underscored the importance of ATM
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phosphorylation for its biological functions. ATM is predominantly localized in the nucleus, and
is activated once the MRN complex senses and binds to DSB ends, thus providing a platform for
ATM recruitment and auto-phosphorylation 59, 60. Phosphorylation of S1981 also stabilizes ATM
at the damaged DNA sites and recruits more downstream effector proteins to participate in the
DDR 61. Among the multiple substrates phosphorylated by ATM is CHK2, which is
phosphorylated at residue T62 following DSB formation and prevents cells from progressing
from G1 to S phase or, alternatively, leads to cell apoptosis.
Our results demonstrated that, concomitant with the ATM deficiency, the
phosphorylation of CHK2 was defective in CD4 T cells during HIV infection. Moreover,
siRNA-mediated silencing or pharmacological inhibition of ATM in healthy T cells also led to
the CHK2 defect, which was accompanied by dramatic DNA damage and cell apoptosis mimicking the biological defects we observed in HIV-derived CD4 T cells. These results
establish that in human T cells, CHK2 is targeted by ATM and that the overall defect of this
signaling pathway can be attributed to ATM insufficiency, driven by chronic HIV infection.
Further investigations of the molecular mechanisms regulating the posttranscriptional expression
and phosphorylation/dephosphorylation of these DDR kinases will shed new lights onto the
cellular machinery that contributes to DNA repair and cell homeostasis.
Recently, Li et al. 62 identified prematurely aged T cells with damaged telomeres in
patients with rheumatoid arthritis resulting from defective activity of the DNA break sensor
MRE11A. In patients with latent HIV infection, however, we found an intact DNA damage
sensor MRN complex in CD4 T cells. However, ATM was inhibited at the posttranscriptional
level in these cells, which produced considerable amounts of ROS. Interestingly, Guo et al. 63, 64
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similarly reported that ATM activation in response to ROS was independent of the MRN
complexes. ROS-mediated ATM signaling represses mTORC1 signaling, and therefore cell
growth and proliferation through the activation of TSC2 (a negative regulator of mTOR) by liver
kinase B1 (LKB1) and AMP-dependent protein kinases (AMPKs) 65. ATM engagement of the
TSC2/mTORC1 signaling node can also regulate autophagy 66, and differential localization of
ATM correlates with activation of distinct downstream signaling pathways 67. We have recently
reported that T cells derived from chronic HCV infection also exhibit pronounced telomeric
DNA damage due to remarkably elevated ROS, with intact DNA damage sensors MRN complex
but impaired ATM/CHK2 signaling pathway 19, 20. Investigation is underway in our laboratory to
detail the mechanisms of ROS-mediated ATM deficiency during latent HIV infection.
It should be pointed out that ATM, as a key kinase in DDR, can be activated in the early
phase of DNA damage, as observed in our in vitro model, in which pATM, pCHK2, and pAKT
were upregulated, whereas their total protein levels were downregulated in CD4 T cells
following active HIV infection. These changes led to a global loss of ATM, CHK2, and AKT,
which suggests an activation and a subsequent exhaustion or senescence process. Notably, ATM
is widely expressed in human T cells at an extremely high level to ensure integrity of genomic
DNA in replicating lymphocytes. Its activation may represent the initiation of DDR process, but
its inhibition and insufficiency in persistently activated T cells indicate deficiency in DNA repair
that can promote cell exhaustion and senescence in the setting of chronic viral infection. This
notion is also supported by our observation in the in vitro stimulated T cell system in which
ATM phosphorylation was elevated in the early phase of KML001 (a telomere targeting drug)treated T cells (3~6 h), but decreased with the treatment for longer periods (24~48 h), and
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associated with increases in DNA damage, cell apoptosis and functional impairment
(unpublished observations).
As noted above, our data demonstrated that both ATM and CHK2 expression and
activation were ultimately diminished in the setting of latent HIV infection on ART. This was
present in T cells from our in vivo population of HIV-infected subjects on ART and matched our
in vitro T cells infected with HIV in the presence of an integrase inhibitor, RAL. Interestingly,
this drug was added very early (2 h) after HIV was introduced into the cells, but led to dramatic
reduction in ATM, CHK2 and their phosphorylated moieties when compared to uninfected T
cells exposed to RAL. These data beg the question of whether it is even feasible to avoid
disruption of telomeric DDR signaling and cellular senescence/apoptosis in the HIV-infected
host without actually targeting the repair machinery itself. Consistent with our findings,
Rossiello and Fumagalli et al. 68, 69 reported that telomeric DNA damage in mammalian cells is
irrepairable and occurs preferentially at telomeres in linear genomes. Their studies suggested a
paradigm in which cellular senescence and organismal aging resulting from persistent DNA
damage signaling and accumulated, irrepairable telomeric DNA damage could be permanent via
a shared causative mechanism; i.e., once damaged, they remain damaged. Other data suggested
that persistent DDRs may trigger senescence-associated inflammatory cytokine secretion,
facilitating communication of a compromised state to the surrounding cells 70. Similarly, a
bystander effect in which senescent cells induce DDR via cell-cell contact and generate ROS to
proximate cells within the milieu, a senescence-induced senescence 71. These could certainly
occur in our model, given that we observed DDR effects after a short period despite the
treatment with ART. Importantly, latently HIV-infected cells are more susceptible to DDR-
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inducing agents, and thus are vulnerable to DDR-induced cell apoptosis 72. Sensitivity to DDR
highlights a unique vulnerability of latently infected cells, a new feature that could potentially be
exploited in developing therapeutics to eliminate HIV-1 reservoirs. Further studies to explore the
DDR triggers are underway in our laboratory.
We and others have shown poor vaccine (HAV, HBV, Influenza, and Pneumovax)
responses in the setting of chronic viral (HCV, HIV) infections 11-16, 73-79, but the underlying
mechanisms for vaccine failure in virally-infected individuals remain elusive. Our new findings
herein indicate that CD4 helper T cells in chronically HIV-infected patients have abnormalities
that jeopardize their ability to mount effective immune (vaccine) responses. The immune system
is in constant turnover during viral infection, with high demands for lymphocyte replenishment
to maintain the equilibrium of the T cell compartment. In this regard, insufficient activation of
ATM would be expected to affect both unprimed and primed T cells, but memory T cells would
over-expand rapidly with greater DNA damage and cell apoptosis, which could compromise the
size and survival rate of the naïve T cell repertoire. Indeed, ongoing antigenic and/or
inflammatory stimulation during chronic viral infection induces continuous differentiation of the
naïve T cells and turnover of antigen-reactive T cells, resulting in telomere erosion and cell
senescence or apoptosis, which we observed more prominently in the memory T cells.
Eventually, the majority of the T cell pool would be comprised of antigen-expanded T cells at
the expense of naïve T cells. With the decrease in newly generated naïve thymic T cells in adults,
chronic inflammation or infection might force the immune system to restore equilibrium by
replicating the existing naïve T cells, thereby driving telomere shortening and senescence in
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naïve T cell populations in the peripheral blood. Thus, the ability to generate immune response to
new antigens, such as vaccines, would be compromised.
In summary, accumulation of DNA damage and failure of repair due to deficiency of the
ATM-dependent DNA repair machinery during chronic viral infection may broadly impair diverse
cellular functions. Counteracting ATM deficiency may restore T cell homeostasis and competency
during chronic viral infection and prevent premature immune senescence. This study reveals a
novel molecular mechanism underlying T cell senescence, and provides a new strategy to correct
an aberrant immunopathology, to avoid the untoward consequences of immunosenescence, and to
improve immunotherapy and vaccine responses against human viral diseases.
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CHAPTER 4
SUMMARY AND FUTURE DIRECTION
Summary
T cells play a crucial role in viral persistence and vaccine responses; however, the
mechanisms regulating their responses to viral infection or vaccinations remain elusive. We and
others have previously shown that T cells derived from patients with chronic viral infections
prematurely reach senescence, characterized by the overexpression of aging markers, such as
p16ink4a, p21cip1, CD57, and KLRG1, differential regulation of aging-associated microRNA-21/181a, and particularly, shortened telomeres. In this study, we investigated T cell homeostasis,
apoptosis, DNA damage and repair machineries in a large cohort of subjects with chronic HCV
or HIV infection. we demonstrate that:
1) Homeostatic remodeling of CD4 T cells during HCV infection primarily affects
the naïve T cell compartment, whereas HIV infection mainly depletes memory CD4 T cell
pool, characterized by an accumulation of DNA damage due to insufficient activation of the
DNA repair kinase ATM, leading to CD4 T cell apoptosis and loss.
2) Phosphorylation (activation) of ATM in T cells exposed to HCV or HIV is
inhibited through dampening the PI3K pathway, resulting in an increase in unrepaired DNA
damage and cell apoptosis.
3) Silencing ATM expression or pharmacological inhibition of ATM
phosphorylation leads to more DNA damage and apoptosis in CD4 T cells. Conversely,
reconstitution of ATM repairs the DNA damage, cell apoptosis, and functional defects in
CD4 T cells derived from both HCV- and HIV-infected individuals.
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Based on these novel findings, we propose a model, as depicted in Fig.2.7 and Fig 3.7,
where HCV- or HIV-induced ATM deficiency leads to accumulation of DNA damage and cell
apoptosis. The excessive naïve and/or memory CD4 T cell loss necessitates high homeostatic
proliferation and imposes replicative stress on unprimed naïve T cells, further accelerates
premature T cell aging and cellular dysfunction. This study reveals a novel mechanism by which
ATM deficiency promote T cell apoptosis and senescence, and provides a new therapeutic target
for virus-induced immune dysfunction during chronic infection.

Future direction
Mechanisms Involved in ATM Inhibition in T Cells During Viral Infection
While we have demonstrated ATM deficiency in T cells from HCV and HIV
infection, how ATM expression and activity are inhibited by the viral infection is yet
elucidated. We will define which specific proteins from HCV and HIV virus are responsible
for suppressing ATM expression and activation. In addition, since ATM inhibition is
primarily found at the posttranscriptional level, the role of microRNA-21/-181s, which had
been shown to be differentially regulated in T cells from individuals with HCV or HIV
infection, in translational suppression of ATM protein expression will be investigated in
future. Also, the role of protein ubiquitin degradation, the role of AKT/PI3K in
phosphorylation, and the role of DUSP6/PP2A in dephosphorylation of ATM in senescent T
cells, will be further studied in the setting of chronic viral infections.
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Mitochondrial Dysfunction and ROS Production in T Cells During Viral Infection
An emerging paradigm in human immunology indicates that cellular metabolic
reprogramming is tightly linked with the immune activation and function. Specifically, T cell
activation results in an increase in mitochondrial respiration, which is associated with an
increase in the production of ROS during chronic viral infection. Overproduction of ROS
may directly decrease mitochondrial membrane potential and lead to a lower ATP supply,
causing mitochondrial network fragmentation and subsequent, cell apoptosis, or cell
senescence. Thus in future, we will determine ROS metabolism in dysregulated T cells
during chronic HCV or latent HIV-1 infection. Specifically, we will compare the ROS levels
in naïve and memory CD4 T cells derived from virally infected patients versus HS. We will
also characterize the mechanisms of ROS production by determining the non-enzymatic
antioxidant GSH and enzymatic antioxidants SOD, NAPDH and Catalase levels during
chronic viral infections.

The Interplay between ROS and ATM in TV Cells During HIV-1 Infection
Besides functioning as a master regulator of the DDR, ATM also responds directly to
the oxidative stress and regulates multiple cellular signaling pathways. For example, ATM
kinase has been shown to negatively regulate ROS production. In addition, blocking ATMmediated DDR during oxidative stress resulted in deficiencies in mitochondrial function and
autophagy. The interplay between ROS and ATM during chronic viral infection has not been
studied yet. Understanding how ROS contribute to the telomeric DDR and promote
premature T cell aging via dysregulating the ATM pathway, and whether ATM can feedback
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regulate ROS metabolism, may raise the possibility of developing novel therapeutic targets
for inflammaging-induced immune dysfunction during chronic viral infection.
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APPENDIX
ABBREVIATIONS
53BP1

p53-binding protein 1

7AAD

7-Aminoactinomycin D

8-oxoG

8-oxogunine

AIDS

Acquired immune deficiency syndrome

AKT

Protein Kinase B

AMPKs

AMP-dependent protein kinases

ART

Antiretroviral therapy

AT

Ataxia telangiectasis

ATM

Ataxia telangiectasia mutated

ATR

Ataxia telangiectasia Rad3-related

Av

Annexin V

bp

Base pairs

CHK1

Checkpoint kinase 1

CHK2

Checkpoint kinase 2

CMV

Cytomegalovirus

DAA

Direct acting antiviral

DAPI

4′,6-diamidino-2-phenylindole

DCFDA

Dichloroflurescin diacetate

DDR

DNA damage response

DMSO

Dimethyl sulfoxide
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DNA-PKc

Protein kinase catalytic subunit c

DSB

Double strain breaks

DUSP6

Dual specificity phosphatase 6

EBV

Epstein-Barr virus

FMO

Fluorescence minus one

GFP

Green fluorescent protein

GSH

Glutathione

H2AX

Histone family member X

HCC

Hepatocellular carcinoma

HCV

Hepatitis C virus

HIV

Human immunodeficiency virus

HNK1

Human natural killer 1

HS

Healthy subjects

IL-2

Interleukin-2

INF-γ

Interferon gamma

IRB

Institutional review board

KLRG1

Killer cell lectin-like receptor subfamily G member 1

LKB1

Liver kinase B1

MFI

Mean florescence intensity

miR

MicroRNA

MRE11

Double-strand break repair protein

MRN

MRE11, RAD50 and NBS1
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mTOR

mammalian target of rapamycin

NAPDH

Nicotinamide adenine dinucleotide phosphate hydrogen

NHEJ

Non-homologous end joining

NS

No significance

PARP-1

Poly ADP-Ribose Polymerase 1

PBMC

Peripheral blood mononuclear cell

PD-1

Programmed cell death protein 1

PEI

Polyethylenimine

PIKK

Phosphatidylinositol 3-kinase-related kinase

PI3K

Phosphatidylinositol 3-kinase

RAL

Reltegravir

ROS

Reactive oxygen species

RT-PCR

Reverse transcription polymerase chain reaction

SOD

Superoxide dismutase

STK1

Serine/threonine kinase 11

TBS

Tris buffered saline

TCR

T cell receptor

TIF

Telomere induced foci

Tim-3

T-cell immunoglobulin and mucin-domain containing-3

TRF1

Telomeric repeat-binding factor 1

TRF2

Telomeric repeat-binding factor 2

TSC2

Tuberous sclerosis complex 2
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